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Abstract 
Viral infections of the kidney, with severe clinical pictures, represent an ongoing threat. The 
hemorrhagic fever with renal syndrome (HFRS) is caused by several species of pathogenic Old World 
hantaviruses and is clinically characterized by cellular permeability disorders, leading to acute kidney 
injury. Previously, it was shown that podocytes and tubular epithelial cells, which play a key role in 
renal function, are permissive for hantaviruses and further, that the infection was causing a 
disruption of cell-to-cell contacts correlating with the disease severity. Up until today, the renal-
specific pathogenesis mechanisms of hantavirus infections, leading to the cellular leakage, are not 
well understood. In this study, functional and morphological consequences of hantavirus infection 
are examined in human renal cells and compared to African green monkey Vero E6 cells, which are 
commonly used to study hantaviruses. 
Analysis of podocytes and tubular epithelium in human renal biopsies of hantavirus-infected patients 
revealed distinct morphological changes known to be involved in functional disorders of various 
kidney diseases. To investigate how hantaviruses cause cellular disorders, the effects were further 
examined using in vitro experiments. Infections of podocytes and tubular epithelial cells with either 
Hantaan (HTNV) or Puumala virus (PUUV) caused cytoskeletal rearrangements in combination with 
an impairment of adhesion and motility capacity. The nucleocapsid (N) protein was associated with 
the actin cytoskeleton and, in addition to that, the integrity of filamentous (F-) actin was crucial for 
viral release. Furthermore, the transfection of podocytes revealed that the expression of N protein 
alone was sufficient to impair cellular functions. Soluble factors contributing to the cellular 
disturbances were neither detected in the supernatant of in vitro infected podocytes nor in the 
serum of hantavirus-infected patients, indicating direct effects of infection on renal cells. According 
to the severity of the clinical picture, the in vitro effects of hantaviral infections and N protein 
expression were more pronounced for HTNV than for PUUV. In contrast, the hantavirus infections 
were clearly different in Vero E6 cells and no functional consequences and actin involvement were 
observed, demonstrating the importance of choosing relevant cell culture models. 
These results demonstrate that hantavirus-induced morphological and functional injuries are species- 
and cell type-specific. The association of N protein with actin and its involvement in the viral release 
might play a role in the underlying mechanism, leading to functional impairment and cell-to-cell 
contact disruption. Moreover, the N protein is identified to be a pathogenicity factor of Old World 
hantaviruses. Conclusively, these findings might contribute to the understanding of the pathogenesis 
mechanisms leading to the clinical picture of hantavirus-induced acute renal failure. 
 
Zusammenfassung 
Virale Infektionen der Niere, mit schweren Krankheitsverläufen, stellen eine ernstzunehmende 
Bedrohung dar. Das hämorrhagische Fieber mit renalem Syndrom (HFRS) wird von verschiedenen 
pathogenen Altwelt-Hantaviren verursacht und ist durch Störungen der Zellpermeabilität 
gekennzeichnet, welche zu einem akuten Nierenversagen führen. Es konnte gezeigt werden, dass 
Podozyten und Tubulus-Epithelzellen, welche eine Schlüsselrolle in der Nierenfunktion einnehmen, 
permissiv für Hantaviren sind und dass die Infektion zu einem Zusammenbruch der Zell-Zell Kontakte 
führt. Bis heute ist der spezifische Pathomechanismus von Hantaviren nicht komplett aufgeklärt. In 
dieser Studie werden die funktionalen und morphologischen Konsequenzen der Hantavirusinfektion 
untersucht und mit Vero E6 Zellen aus der afrikanischen grünen Meerkatze verglichen, welche 
üblicherweise zur Untersuchung von Hantaviren benutzt werden. 
Auswertungen diverser Nierenbiopsien von Hantavirus-infizierten Patienten, mit Fokus auf 
Podozyten und das Tubulus-Epithel, zeigten morphologische Veränderungen, welche dafür bekannt 
sind, verschiedenen Nierenerkrankungen auszulösen. Die verursachten Zellschädigungen durch 
Hantaviren wurden in in vitro Experimenten weiter untersucht. Die Infektion von Podozyten und 
Tubulus-Epithelzellen mit Hantaan (HTNV) oder Puumala Virus (PUUV) führten zu einer Veränderung 
des Zytoskeletts, sowie zu einer Verminderung der Adhäsion und Beweglichkeit der Zellen. Das 
Nukleokapsid- (N-) Protein war entlang des Aktin-Zytoskeletts lokalisiert und die Integrität von 
filamentösem (F-) Aktin war von großer Bedeutung für die Freisetzung von neuen Viruspartikeln. Die 
alleinige Expression von N-Protein verursachte Zellschädigungen in transfizierten Podozyten. Lösliche 
Faktoren, welche zu den funktionalen Beeinträchtigungen führen können, waren weder in 
Überständen von infizierten Podozyten noch in Patientenseren zu finden, weshalb auf direkte Effekte 
der Infektion auf die Zellen geschlossen werden kann. Die in vitro Beobachtungen der Infektion und 
der N-Protein Expression stimmten mit dem Krankheitsbild überein, bei dem HTNV einen schwereren 
Verlauf als PUUV aufweist. Funktionale Konsequenzen und eine Beteiligung des Aktin-Zytoskeletts 
waren in Hantavirus-infizierten Vero E6 Zellen nicht zu finden. Diese Beobachtung zeigt, dass die 
Wahl eines relevanten Zellkulturmodells für die Untersuchung von Hantaviren von Bedeutung ist.  
Die Ergebnisse beweisen, dass morphologische und funktionale Zellschädigungen durch Hantaviren 
sowohl spezien-, als auch zellspezifisch sind. Die Lokalisierung von N-Proteinen an F-Aktin und die 
Freisetzung von neuen Viruspartikeln sind möglicherweise an dem Mechanismus, der zu funktionalen 
Beeinträchtigung sowie zum Zusammenbruch der Zell-Zell Kontakte führt, beteiligt. Diese Studie 
identifiziert außerdem die N-Proteine von Altwelt-Hantaviren als Pathogenitätsfaktor. 
Zusammenfassend tragen diese Erkenntnisse dazu bei, den Pathomechanismus von Hantaviren, 
welcher zu einem akuten Nierenversagen führt, zu verstehen. 
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Introduction 1 
1. Introduction 
1.1 Virus-induced kidney diseases  
In recent times, the amount of patients with severe kidney disease continuously increased and is 
displaying a public health problem [1]. Inflammations of the human kidney and the adjacent urinary 
tract are among the most common infectious diseases in humans. Viral infections are representing 
important causative agents for renal injury and failure. Viruses affecting renal function are often 
associated with immunocompromised or immunosuppressed hosts. During kidney transplantations, 
the reactivation of the cytomegalovirus (CMV) or the BK-virus (BKV) represents a hazard leading to 
complications and in the worst case to a loss of renal grafts [2, 3]. Renal dysfunction and injuries are 
also described in the course of the clinical picture in chronic viral infections, such as the hepatitis C 
virus (HCV) or the human immunodeficiency virus (HIV) [4, 5]. In contrast, viral hemorrhagic fever 
(VHF) caused by Hantaviruses, Dengue virus or Ebola virus is associated with acute kidney injuries [6, 
7]. Due to the emerging number of cases and outbreaks worldwide displaying severe clinical pictures 
and fatality within the last decades, VHF-causing hantaviruses gained an increased interest of viral 
renal research. 
 
1.2 Hantaviruses 
1.2.1 Epidemiology of hantaviruses 
Hantaviruses, belonging to the order of bunyavirales, are a zoonotic viral disease and maintain as a 
persistent infection of rodents. Since outbreaks during the Korean War (1950-53) and the isolation of 
the causative agent, named Hantaan virus (HTNV) in 1976, more than 41 pathogenic and non-
pathogenic species have been found worldwide with the exception of Australia [8, 9]. Each 
hantavirus is associated with a single species of wild rodents, which serves as its natural reservoir 
und thereby determines the geographical distribution. The hosts are lifelong, chronically, and 
asymptomatically infected and excrete infectious hantaviral particles by urine, feces, and saliva [10, 
11]. Transmission of hantaviruses to humans occurs predominately by inhalation of contaminated 
aerosolized rodent excretes. Person-to-person transmission was only sporadically reported for Andes 
virus (ANDV) in Argentina [12, 13]. Humans are exposed to an increasing risk of infection during 
leisure time or professional activities in the natural habitat of host species [14]. Individual risk factors 
such as certain gene polymorphisms or smoking were also reported [15-17]. The incidence of disease 
is described to be greater for males and young adults and in contrast is rare in children and the 
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elderly [18]. Behavioral differences of males may account for the observation that more men are 
affected. Nevertheless, possible gender-specific factors determining the severity of hantavirus 
disease are controversially discussed [19-21]. 
The first cases in Europe and Germany were described in 1980 and 1986, respectively [22, 23]. Since 
2001, a hantavirus infection is notifiable in Germany and the Robert Koch Institute classifies 
hantaviruses to the highest priority group of pathogens [24]. In 2016, the European Centre for 
Disease Prevention and Control reported that hantaviruses are widely endemic across Europe [25]. 
Two pathogenic hantaviruses, causing the majority of clinical infections, are found along with their 
natural hosts: Puumala virus (PUUV), transmitted by bank voles (Myodes glareolus), throughout most 
of Europe with the exception of Mediterranean countries, and Dobrava-Belgrade virus (DOBV) spread 
by the yellow-necked mouse (Apodemus flavicollis) in Eastern and Central Europe. The majority of 
cases were reported in Finland, Sweden, Germany, Croatia, and France. Numbers of hantavirus cases 
in Germany undergo fluctuations and are associated with climatic changes and environmental 
parameters affecting the rodent population (Fig.1) [26]. 
 
 
 
Figure 1 Annual numbers of reported cases of hantavirus disease in Germany since 2001. The asterisk (*) 
indicates cases in 2017 until 12/09/2017 (Source: SurvStat of Robert Koch Institute [27]). 
 
 
1.2.2 Clinical picture of hantaviruses 
Spillover of hantaviruses to humans has the potential to cause two types of acute disease. Old World 
hantaviruses in Europe and Asia cause hemorrhagic fever with renal syndrome (HFRS) with about 
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150,000 to 200,000 annually reported cases [28]. In addition, about 200 cases are described each 
year for hantavirus in the New World inducing hantavirus cardiopulmonary syndrome (HCPS) [29]. 
The incubation time upon exposure to HFRS-causing hantaviruses such as HTNV or DOBV usually 
ranges from two to three weeks. The following febrile phase is characterized by a sudden onset of 
unspecific flu-like symptoms such as high fever, cephalgia, myalgia, accompanied by myopia, 
gastrointestinal symptoms, nausea, vomiting, abdominal and flank pain. Hemorrhages can occur and 
display as injection of the conjunctiva, petechial rush or even as gastrointestinal hemorrhage. In the 
hypotensive phase, patients suffer from vascular leakage potentially leading to shock, tachycardia 
and hypoxemia. Characteristically for hantavirus disease is the occurrence of leukocytosis, elevated 
levels of lactate dehydrogenase (LDH), and C-reactive protein (CRP). The subsequent oliguric phase is 
the most critical stage and is responsible for over 50% of hantavirus-related deaths. The systemic 
disease starts to primarily manifest in the kidney and is associated with the onset of renal failure and 
loss of blood proteins, called proteinuria. Laboratory findings include the decrease of serum albumin 
and an increase of serum creatinine levels. The renal filtration starts to improve in the following 
polyuric phase and recovers in the convalescent phase. PUUV infections in Europe generally cause a 
mild form of HFRS, called nephropathia epidemica (NE), and severe symptoms like hemorrhages and 
shocks are rare [30, 31]. 
New World hantavirus-induced HCPS shares similarities with the clinical picture of HFRS, with the 
exception that capillary leakage mainly manifests in the lung. The disease is usually more severe and 
patients suffer from initial symptoms like shortness of breath, which are rapidly developing into an 
acute respiratory failure. The mortality rate of HCPS is high and varies between 25% and 40% [32]. 
The reason for the different organ manifestations, however, is unclear. Clinical findings revealed that 
a distinction between HFRS and HCPS is not always possible since renal and lung involvement has 
been reported for both diseases [33, 34]. 
Nevertheless, the kidney involvement with massive proteinuria is a hallmark of Old World hantavirus 
infection. The severity is determined by the hantavirus species that causes the disease and differs 
enormously (Tab. 1). Dialysis is required for about 40% of HTNV-, 16-48% of DOBV-, and 5% of PUUV-
infected patients [28, 35]. In addition, the case-fatality rate ranges from up to 15% for HTNV, up to 
12% for DOBV and less than 0.4% for PUUV infections [31, 36-39]. Interestingly, even highly related 
genotypes of DOBV vary in their virulence to humans (Tab. 1) [40]. The mechanisms behind the 
different severities of the disease are unknown.  
At present, only hantavirus-induced symptoms can be medicated to keep the severity under control 
since no specific hantaviral therapy or effective vaccines are available [41]. An early treatment of 
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hantavirus-infected patients with the nucleoside analog ribavirin is discussed controversially and 
differs in the efficacy and safety depending on the virus species [42, 43]. 
 
 
Table 1 Selection of pathogenic Old World hantaviruses with associated case fatality rates. 
Virus species Distribution Disease Case fatality Source 
Puumala virus (PUUV) Central, Northern Europe HFRS (NE), mild 0.4% [36] 
Hantaan virus (HTNV) Asia HFRS, severe 5-15% [31] 
Dobrava-Belgrade virus (DOBV) 
 Dobrava (DOBV-Af) 
 Sochi (DOBV-Ap) 
 Kurkino (DOBV-Aa) 
 
Balkans 
Crimea  
Central, Eastern Europe 
 
HFRS, severe 
HFRS, moderate 
HFRS, mild 
 
10-12% 
6% 
<1% 
 
[37] 
[38] 
[39] 
 
 
1.2.3 Virology of hantaviruses 
1.2.3.1 Virion and genome structure 
Despite specific endemic distribution and differences in the severity of the clinical picture, 
hantaviruses share a common virion structure and high genome homology (Fig. 1). The virion is 
enveloped and possesses a trisegmented negative-sense, single-stranded RNA genome of about 
12,000 nucleotides. Each segment consists of one open reading frame (ORF) and the small (S), 
medium (M) and large (L) segment encode for the nucleocapsid (N) protein, a polyprotein, which is 
cotranslationally cleaved into the glycoproteins Gn and Gc, and the RNA-dependent RNA 
polymerase (RdRP), respectively [44]. However, an overlapping ORF in the S segment exists in several 
hantavirus species encoding for a functional nonstructural protein counteracting interferon-β 
activation [45]. The two glycoproteins Gn and Gc are organized in spike-like complexes and 
embedded into the viral envelope. The segments of the genome are encapsulated by N proteins 
forming the ribonucleoprotein (RNP) complexes and are enclosed inside the viral membrane.  
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Figure 1 Schematic structure of the hantaviral particle. Hantaviruses consist of a trisegmented negative-sense, 
single-stranded RNA genome. The segments small, medium, and large are encapsulated in a complex with the 
N protein and the RNA-dependent RNA polymerase. The lipid envelope is coated by glycoproteins arranged in 
spikes (Image adapted from Vaheri et al. [46]). 
 
 
1.2.3.2 Hantaviral replication cycle 
Virus entry into host cells is mediated by attachment to cellular receptors. For pathogenic 
hantaviruses, integrin αvβ3 has been described as main entry receptor and, in addition, decay-
accelerating factor (DAF/CD55) and gC1qR act as critical cofactors [47-49]. Followed by different 
pathways of endocytosis, the RNPs are released to the cytoplasm from late endosomes by pH-
mediated fusion of viral and endosomal membranes [50-53]. The site of viral replication and/or 
transcription is suggested to be located at processing bodies and at endoplasmic reticulum-Golgi 
intermediate compartment (ERGIC) [50, 54]. Hantaviruses use different assembly sites and egress 
pathways and it seems that Old World hantaviruses bud at the ER, Golgi complex and plasma 
membrane, while New World hantaviruses bud exclusively at the plasma membrane [55-58].  
Hijacking of intracellular pathways is an overall requirement for an efficient transport of viral RNA 
and proteins to sites of replication, assembly, and release. In several studies, the role of the 
cytoskeleton was analyzed during hantavirus infection. African green monkey Vero E6 cells and baby 
hamster kidney-21 (BHK-21) cells were used and revealed a different utilization of host cytoskeleton 
components and partially contradictory results. Early studies by Ravkov et al. on the morphogenesis 
of New World Black Creek Canal virus (BCCV) in Vero E6 cells revealed a filamentous pattern of N 
protein, which was associated with F-actin and the disruption of actin resulted in a decreased release 
of infectious particles [59]. Moreover, the transfection of BHK-21 cells with BCCV and PUUV N 
protein-encoding plasmids also revealed a filamentous pattern indicating an actin localization [60]. In 
subsequent publications, Ramanathan et al. showed that hantavirus species differ in their 
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localizations and dependency of cytoskeletal components in Vero E6 cells [50, 51]. While the entry 
was enabled by F-actin and microtubules for all hantaviruses, New World hantaviruses depend on 
actin for late events and Old World hantaviruses require intact microtubules during assembly and 
release. Interestingly, neither effects of F-actin disruption nor a filamentous pattern of BCCV, as seen 
by Ravkov et al., were detected in the studies of Ramanathan et al., although Vero E6 cells were used 
in both studies. Discrepancies in the experimental conditions might contribute to the contradictory 
results such as differences in the multiplicity of infection (MOI) for viral infection or choosing of 
varying points of time for the observation. Moreover, Vero E6 cells are interferon-deficient and do 
not secrete interferons like normal mammalian cells, which might influence the viral replication 
cycle.  
 
1.3 Pathogenesis of Old World hantaviruses 
1.3.1 Target cells  
The exact pathogenicity factor, responsible for the different organ manifestation and clinical 
symptoms of hantavirus species, has not been elucidated. The use of a relevant cell culture model or 
organism is mandatory for the study of the pathogenesis since Vero E6 cells already show no reliable 
results in the viral replication cycle.  
Up until today, no appropriate animal infection model has been found that completely recapitulates 
severe human HFRS. Therefore, research is hampered to study multifaceted processes in an 
organism. Experimental inoculation of adult or suckling small laboratory animals such as mice, rats 
and hamsters with various hantaviruses resulted in an asymptomatic and persistent infection or in 
lethal neurological symptoms, which are uncharacteristic for HFRS, respectively [61]. Cynomolgus 
macaques (Macaca fascicularis) infected with PUUV developed a mild form of HFRS, which is similar 
to NE in humans [62-64]. The clinical picture of macaques displayed hantavirus-characteristic 
symptoms and deteriorated clinical parameters such as proteinuria and elevated levels of creatinine 
and CRP. Since no small animal model for hantavirus infection exists and the macaque model is 
limited, in vitro cell culture and human biopsy or blood samples are commonly used to study the 
pathogenesis of hantavirus disease. 
Humans demonstrate a wide range of target cells for Old World hantavirus infection. Analysis of in 
vitro infections showed that different endothelial and epithelial cell lines and primary cells of kidney, 
lung and liver, as well as immune cells, are permissive for hantaviruses [65-68]. This wide range of 
tropism might explain the different symptoms during the clinical picture. Analysis of biopsies and 
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autopsies of humans and monkeys revealed that viral antigen, particles, and RNA can be found in 
different organs such as kidney, liver and spleen [62, 65, 69-71]. Moreover, extrarenal involvement 
during disease was reported and hantaviral antigens have been found in the intestine and hypophysis 
of human tissue samples and might be involved in the development of abdominal pain, headache, 
fatigue, and central nervous system complications [72-74]. The reason for the different organ 
manifestations during the clinical course of disease is not completely understood. Nevertheless, the 
kidney and its function are predominantly affected by Old World hantaviruses in humans and 
macaques leading to proteinuria and renal failure.  
 
 
 
 
Figure 2 Schematic structure of kidney, nephron and glomerulus. (A and B) Nephrons are the functional renal 
subunits of the kidney and are divided into the renal corpuscle and the adjacent renal tubule. (C) Within the 
renal corpuscle, the blood is filtrated at the capillaries of the glomerulus by the filtration barrier consisting of 
endothelial cells, glomerular basement membrane and podocytes. The filtrate is further processed by 
reabsorption of essential molecules in renal tubules and finally excreted in form of urine (Image adapted from 
Kurts et al. [75]). 
 
 
1.3.1.1 The kidney as major target for Old World hantaviruses 
The analysis of kidney biopsy specimens of hantavirus-infected patients further revealed that viral 
antigen can be found in cells of the glomerular and tubular apparatus [65]. Both structures are 
located in the nephron, the smallest renal subunit, and are essential for blood filtration and urine 
processing (Fig. 2A and B). Analysis of in vitro infection studies with human renal cells showed that 
  
Introduction 8 
primary glomerular endothelial cells and podocytes, as well as primary tubular epithelial cells, are 
permissive to Old World hantavirus infection and release of infectious particles [65].  
The glomerulus is a network of blood capillaries located at the renal corpuscle at the start of each 
nephron and functions as the blood filtration unit of the kidney. The glomerular filtration barrier 
(GFB) consists of three layers (fenestrated endothelial cells, glomerular basement membrane (GBM) 
and podocytes) and is impermeable for large proteins and blood cells, but allows the passage of small 
molecules (Fig. 2C) [76]. 
During filtration, podocytes play a key role and form the basic backbone of the GFB. Podocytes 
consist of a complex structure. Proceeding from the cell body, major processes arise and split into 
multiple foot processes (FP) (Fig. 2C and 3A). The FPs of neighboring podocytes form a tight 
interdigitating network wrapping the outer surface of the glomerular capillaries and are 
interconnected by multiprotein complexes of the glomerular slit diaphragm (GSD) [77, 78]. Crucial for 
proper podocyte function and the integrity of FPs are highly-ordered actin filament bundles [79]. In 
recent years, the view of podocytes as a static molecular sieve has been changed into a highly 
regulated dynamic structure. Rapid reorganization of the actin-based cytoskeleton of FPs allows 
podocytes to migrate along the GBM in order to react to different environmental conditions such as 
hydrostatic stress. Proteins regulating the actin cytoskeleton are therefore of critical importance to 
maintain podocyte function [80]. Interference with signaling pathways controlling the actin 
cytoskeleton during kidney disease leads to changes of the actin organization and a deteriorated 
motility capacity of podocytes. It was shown that hypo- and hypermotility of podocytes can result 
into a loss of proper interdigitating FPs, which is called effacement (Fig. 3B). Effacement is 
characterized by disruption of the GSD, resulting in disorders of filtration function and proteinuria 
[81-85].  
After passing the GFB, the filtrate is consisting of metabolites for excretion, as well as, water and 
essential molecules such as small proteins, electrolytes, amino acids, or glucose which are 
reabsorbed by the renal tubules into the peritubular capillaries by intracellular and transcellular 
pathways (Fig. 2C) [86-88]. The tubular epithelium maintains a barrier between urinary lumen and 
the interstitial tissue and their ability to migrate along the underlining basement membrane is of 
crucial importance for reaction to environmental conditions and wound closing [89]. Afterwards, the 
processed filtrate is passed on to the collecting duct and finally excretes the human body in form of 
urine.  
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Figure 3 Podocyte structure. (A) Healthy podocyte. Left: Scanning electron microscopy (SEM) from Bowman’s 
space view. Podocyte consists of a cell body (CB) that is branched into major processes (MP) and foot processes 
(FP). Right: Transmission electron microscopy (TEM) of the glomerular filtration barrier. BS: Bowman’s space; 
CL: capillary lumen; SD: glomerular slit diaphragm; GBM: glomerular basement membrane; E: endothelial cell. 
(B) Podocyte during disease. SEM (left) and TEM (right) show foot process effacement characterized by a loss of 
cell shape and interdigitating FP (*) (Image adapted from Mundel et al. [81]). 
 
 
1.3.1.2 Impairment of kidney function during hantaviral disease 
Histopathological examination of renal tissue of hantavirus-infected humans and macaque infection 
models reveals acute tubulointerstitial nephritis with infiltrates of immune cells and minor changes 
of the glomeruli [62, 90-92]. However, by using electron microscopy analysis, an effacement of 
podocyte FPs is detectable in renal biopsy specimens of hantavirus patients [91]. One hallmark of 
HFRS is a renal permeability dysfunction and proteinuria is found in up to 94% of patients [30, 93]. By 
measurement of the urinary excretion of hantavirus patients, both high- and low-molecular weight 
proteins are found in the urine [94, 95]. Normally, the glomerular filtration barrier is impermeable for 
large proteins and crossed small proteins are completely reabsorbed by the tubular epithelial cells. 
Therefore, the non-selective proteinuria indicates glomerular filtration disorders, as well as, an 
impaired tubular reabsorption capacity during hantavirus disease [85].  
 
1.3.2 Mechanism of pathogenesis 
Hantavirus disease is characterized by leakage of endothelial and epithelial cells, which explains 
many of the underlying symptoms such as hypotension, hemorrhages, and proteinuria. The 
pathogenesis of the glomerular and tubular disorders leading to non-selective proteinuria is not 
completely understood. Research studies of the hantaviral mechanisms in cell culture and renal 
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biopsies suggest that multifaceted mechanisms of immunopathological and direct viral effects play a 
role during hantaviral disease. 
In hantavirus-infected patients, high counts of activated cytotoxic and T helper lymphocytes were 
measured in human blood samples with renal infiltrations of immune cells [92, 96]. Since no obvious 
histomorphological cytopathic effects were detected during infection, it is assumed that the release 
of inflammatory cytokines contributes to the barrier breakdown of endothelial and epithelial cells.  
An intact cell permeability barrier depends on the integrity of cell-to-cell contacts mediated by tight 
and adherens junctions and consist of transmembrane and cytosolic proteins interconnected by the 
cellular cytoskeleton [97]. The GSD of podocytes, a specific variant of adherens and tight junctions, 
and the tight junctions of tubular epithelial cells are important for filtration and reabsorption 
processes, respectively [98, 99]. The barrier function is highly regulated by intracellular pathways and 
extracellular soluble factors [100]. Elevated cytokines levels, which are known to interfere with the 
maintenance of cellular permeability such as interleukin-6 (IL-6), IL-10 and tumor necrosis factor-
alpha (TNF-α) were measured in blood samples of hantavirus-infected patients [101]. Additionally, 
hantaviruses are able to infect dendritic cells, enhance the production of proinflammatory cytokines 
and might directly trigger the release of molecules inducing cellular leakage [67]. Several studies 
examined the role of soluble factors, which are involved in the regulation of cellular permeability. 
They detected elevated levels of vascular epithelial growth factor (VEGF), urokinase plasminogen 
activator receptor (uPAR), and dysregulation of angiopoietins, which correlate with disease severity 
[102-104].  
However, the detection of cytokines in peripheral blood does not explain the organ-specific effects of 
hantavirus infections. Analysis of the underlying direct molecular effects revealed that hantaviruses 
interfere with the susceptibility to extracellular stimuli and integrity of cell-to-cell contacts. In vitro 
infection of human umbilical vein endothelial cell (HUVEC) monolayers demonstrated that HTNV 
induces a prolonged permeability by sensitizing the cellular response to TNF-α and VEGF [104, 105]. 
Moreover, VEGF treatment of HTNV-infected HUVEC but not of uninfected control cells reduced the 
mRNA and protein levels of cell-to-cell contact proteins [104]. A study with human renal cells 
revealed that the barrier function was disturbed by the infection of HTNV in primary human renal 
epithelial cells alone [65]. Biopsy specimens of renal tubules of infected patients demonstrated that 
cellular hantaviral antigen expression correlates with a breakdown and deteriorated localization of 
the tight junction protein zonula occludens-1 (ZO-1) [65]. ZO-1 is a cytosolic protein and links 
transmembranous tight junction proteins with the actin cytoskeleton [106]. Uninfected neighboring 
tubules showed no breakdown of ZO-1 indicating a direct link between viral replication and cellular 
changes [65]. Moreover, a weaker ZO-1 expression was also detected in hantavirus-infected 
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glomerular structures and correlates with disease severity. Cell culture experiments of human 
glomerular endothelial cells, podocytes and tubular epithelial cells infected with HTNV or PUUV 
revealed a breakdown of cell-to-cell contacts as indicated by a decreased expression of ZO-1 and its 
relocalization from the cell borders to perinuclear regions.  
The mechanisms resulting in direct effects are not completely understood. Expression of hantaviral N 
protein executes a plethora of functions. During infection, N proteins play an important role in 
various steps during the viral replication cycle such as encapsulation and replication of RNA [107, 
108]. Besides virus-related functions, the N protein has properties in interfering and modulation of 
host signaling pathways and cell structure [59, 109-111]. The N protein of New World ANDV is 
involved in the regulation of the innate immune system, as well as, in the enhanced permeability of 
microvascular endothelial cells [112, 113]. It remains to be examined whether N proteins of Old 
World hantavirus also contribute to the pathogenesis in renal cells.  
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1.4 Aims and perspectives 
Pathogenic Old World hantaviruses mainly affect the kidney function and cause an enhanced 
permeability and massive proteinuria leading to acute renal failure. This research aims to investigate 
cellular changes by Old World hantaviruses using human renal cells as a relevant in vitro cell culture 
model since most of the previous studies in hantaviral biology and pathogenesis were performed in 
HUVEC and interferon-deficient monkey Vero E6 cells, which differ significantly from renal target 
cells. This project will focus on glomerular podocytes and tubular epithelial cells, which are both 
crucial for kidney function and are affected by hantaviruses in vitro and in vivo. 
 
 
The above mentioned aim will be accomplished by fulfilling the following research objectives: 
 
 Study of morphological changes of cells in renal biopsies by electron microscopy and by in 
vitro cell culture experiments. 
 
 Analysis of subcellular localization of hantaviral N protein. 
 
 Evaluation of the role of cytoskeletal components in hantaviral release. 
 
 Investigation of functional consequences of hantavirus infection in renal cells. 
 
 Examination of soluble factors in cell culture supernatants and human sera contributing to 
cellular renal dysfunction. 
 
 Analysis of the role of N protein in virus-mediated effects on renal function. 
 
 
This research project should provide new insights into the hantaviral pathogenesis of acute renal 
failure and may be of use in the identification of determinants regarding disease severity.  
 
 
 
 
 
  
Material & Methods 13 
2. Material & Methods 
2.1 Material 
2.1.1 Chemicals 
Chemicals Supplier (Location) 
Albumin fraction V (BSA) Carl Roth (Karlsruhe, Germany) 
Ammonium chloride (NH4Cl) Carl Roth (Karlsruhe, Germany) 
Ammonium persulfate (APS) Carl Roth (Karlsruhe, Germany 
Ampicillin sodium salt Carl Roth (Karlsruhe, Germany) 
Bromphenol blue Serva (Heidelberg, Germany) 
Cytochalasin D (Cyto D) Merck (Darmstadt, Germany) 
Dimethyl sulfoxide (DMSO) VWR (Radnor, USA) 
Disodium phosphate (Na2HPO4)  AppliChem (Darmstadt, Germany) 
Distillated water Braun (Melsungen, Germany) 
DRAQ5 BioStatus (Shepshed, UK) 
Endotoxin-free water Promega (Fitchburg, USA) 
Fish gelatin Sigma-Aldrich (St. Louis, USA) 
Glycine AppliChem (Darmstadt, Germany) 
Kanamycin sulfate Carl Roth (Karlsruhe, Germany) 
Mercaptoethanol Merck (Darmstadt, Germany) 
Methanol Sigma-Aldrich (St. Louis, USA) 
Milk powder Carl Roth (Karlsruhe, Germany) 
Monopotassium phosphate (KH2PO4) Merck (Darmstadt, Germany) 
Mounting medium Linaris (Wertheim, Germany) 
N',N',N',N'-tetramethylethylenediamine (TEMED) Carl Roth (Karlsruhe, Germany) 
Nocodazole (NOC) Merck (Darmstadt, Germany) 
Paraformaldehyde (PFA) Sigma-Aldrich (St. Louis, USA) 
Rotiphorese Gel 30 Carl Roth (Karlsruhe, Germany) 
Roti-Transform Carl Roth (Karlsruhe, Germany) 
Sapphire700  LI-COR Bioscience (Lincoln, USA) 
Sodium chloride (NaCl) Sigma-Aldrich (St. Louis, USA) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg, Germany) 
Trishydroxymethylaminomethan (Tris) Carl Roth (Karlsruhe, Germany) 
Triton X-100 Sigma-Aldrich (St. Louis, USA) 
Tween 20 Carl Roth (Karlsruhe, Germany) 
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2.1.2 Buffers and solutions 
Name Amount Chemical 
APS solution 
 
10% (w/v) 
in ddH2O 
 
APS 
Blocking solution  
 
2% (v/v) 
2% (w/v) 
0.2% (w/v) 
in 1xPBS 
FCS  
BSA  
Fish gelatin  
 
 
Cell lysis buffer (6x) 
 
390 mM 
6% (w/v) 
10% (v/v) 
10% (v/v) 
0.5% (w/v) 
in ddH2O 
Tris pH 6.8 
SDS  
Mercaptoethanol 
Glycerol  
Bromphenol blue  
 
 
Fixation buffer  
 
3% (w/v) 
in 1xPBS 
 
PFA 
 
 
Milk blocking solution  
 
5% (w/v) 
in 1xPBS 
 
Milk powder 
PBS (10x) pH 7.2 
 
1200 mM 
180 mM 
250 mM 
25 mM 
in ddH2O 
 
NaCl  
Na2HPO4 
KH2PO4  
Tris  
 
PBST washing buffer 
 
 
0.05% (v/v) 
in 1xPBS 
 
Tween 20 
Permeabilization buffer  
 
0.2% (v/v) 
in 1xPBS 
 
Triton X-100 
 
 
Quenching buffer  
 
50 mM 
20 mM 
in 1xPBS 
 
NH4Cl  
Glycine  
 
SDS blotting buffer 
 
25 mM 
192 mM 
20% (v/v) 
0.05% (w/v) 
in ddH2O 
 
Tris 
Glycine 
Methanol  
SDS  
 
SDS running buffer (10x) 
 
250 mM 
1920 mM 
0.5% (w/v) 
in ddH2O 
 
Tris  
Glycine  
SDS  
 
Tris buffer pH 6.8 
(for stacking gel) 
 
1000 mM 
in ddH2O 
 
  
Tris  
 
 
 
Tris buffer pH 8.8 
(for separation gel) 
1500 mM 
in ddH2O  
Tris  
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2.1.3 Plasmids  
Vector Encoded protein Supplier, Location 
pCR3.1 PUUV N protein Cloned in Section of Nephrology (Heidelberg, Germany) [114]  
pCR3.1 HTNV N protein Cloned in Section of Nephrology (Heidelberg, Germany) [114] 
pmaxGFP maxGFP Lonza (Basel, Germany) 
 
2.1.4 Antibodies 
Primary antibodies 
   Dilutions  
Type Clone Species IF WB ICW Supplier, Localization 
HTNV-N B5D9 mouse  1:100 - 1:100 Progen (Heidelberg, Germany) 
HTNV-N - rabbit  - 1:1000 - Nephrology (Heidelberg, Germany) 
PUUV-N A1C5 mouse  1:100 - 1:100 Progen (Heidelberg, Germany) 
PUUV-N - rabbit - 1:1000 - Nephrology (Heidelberg, Germany) 
Actin - rabbit - 1:200 - Cytoskeleton Inc. (Acoma, USA) 
Tubulin alpha DM1A mouse  1:100 1:1000 - Sigma-Aldrich (St. Louis, USA) 
Synaptopodin - goat 1:20 - - Santa Cruz (Dallas, USA) 
 
Secondary antibodies 
   Dilutions  
Type Conjugate Species IF WB ICW Supplier, Localization 
anti-goat IgG Cy3 donkey 1:1000 - - Jackson Immuno (Newmarket, UK) 
anti-mouse IgG Cy3 donkey 1:1000 - - Jackson Immuno (Newmarket, UK) 
anti-mouse IgG Dylight488  donkey 1:1000 - - Jackson Immuno (Newmarket, UK) 
anti-rabbit IgG Cy3 donkey 1:1000 - - Jackson Immuno (Newmarket, UK) 
anti-mouse IgG IRDye800 donkey - 1:15,000 1:600 LI-COR Bioscience (Lincoln, USA) 
anti-rabbit IgG IRDye680 donkey - 1:15,000 - LI-COR Bioscience (Lincoln, USA) 
 
2.1.5 Cell culture media and supplements 
Description Supplier 
DetachKit for primary cells PromoCell (Heidelberg, Germany) 
DMEM, high glucose (4.5 g/l) Capricorn Scientific (Ebsdorfergrund, Germany) 
Fetal calf serum (FCS), heat-inactivated Biochrom (Berlin, Germany) 
Interferon-gamma (IFN-у) Thermo Fisher Scientific (Waltham, USA) 
Insulin, Transferrin, Selenium Capricorn Scientific (Ebsdorfergrund, Germany) 
PBS without Ca
2+
/Mg
2+ 
Capricorn Scientific (Ebsdorfergrund, Germany) 
Penicillin-Streptomycin Sigma-Aldrich (St. Louis, USA) 
Renal Epithelial Cell Growth Medium-2 PromoCell (Heidelberg, Germany) 
RPMI-1640 Capricorn Scientific (Ebsdorfergrund, Germany) 
Trypsin-EDTA solution Sigma-Aldrich (St. Louis, USA) 
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2.1.6 Cells  
Cell Species Type Origin Supplier 
Podocyte human cell line kidney, derived from 
in vivo podocytes 
 
provided by Prof. Dr. Jochen 
Reiser (Rush University, Medical 
Center, Chicago, USA) [115] 
 
Vero E6 African green  
monkey 
 
cell line Epithelium, kidney ATCC (Manassas, USA) 
Podocyte, primary human primary cell isolated from 
donated human 
tissue 
 
Lonza (Basel, Switzerland) 
Human renal 
epithelial primary 
cell (HREPC) 
human primary cell isolated from adult 
kidney 
PromoCell (Heidelberg, 
Germany) 
 
DH5α 
 
Escherichia 
coli 
 
- 
 
bacteria 
 
Thermo Fisher Scientific  
(Waltham, USA) 
 
2.1.7 Viruses 
Virus Strain Origin 
Hantaan virus (HTNV) 76-118 Isolated from striped field mouse (Apodemus agrarius)  
in South Korea in 1978 [8] 
 
Puumala virus (PUUV) Vranica Isolated from bank vole (Myodes glareolus) 
in Bosnia-Hercegovina in 1986 [116] 
 
2.1.8 Software 
Software Version Supplier, Localization 
EndNote x7 Clarivate Analytics (New York, USA) 
GraphPad Prism 6.01 GraphPad Software (La Jolla, USA) 
Image J 
Chemotaxis tool 
Manual tracking tool 
1.51n 
1.01 
2005/06/15 
National Institutes of Health (Bethesda, USA) 
Ibidi (Martinsried, Germany) 
Fabrice Cordelires (Orsay, France) 
Image Studio  v3 LI-COR Bioscience (Lincoln, USA) 
Office Professional 2010 14.07184.5000 Microsoft (Redmond, USA) 
Photoshop CS6 Adobe Systems (San José, USA) 
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2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Cell lines 
The podocyte cell line, derived from normal human podocytes, was conditionally transformed with a 
temperature-sensitive SV40 large T antigen [115]. For proliferation, cells were cultured in RPMI 
medium supplemented with 10% FCS, 1% penicillin/streptomycin, 1% ITS, and 5000 U IFN-у at 33°C 
and 5% CO2. After transfer to 37°C for 14 days in RPMI medium without IFN-у, podocytes undergo 
growth arrest and express markers of differentiation. Expression of the podocyte-specific marker 
protein synaptopodin was routinely controlled. Experiments were performed with non-proliferating 
and differentiated podocytes. Vero E6 cells were cultivated in DMEM supplemented with 10% FCS 
and 1% penicillin/streptomycin at 37°C and 5% CO2. At a confluence of 70-80%, both cell lines were 
sub-cultivated or seeded for experiments. Therefore, culture medium was discarded and cells were 
washed with PBS. Adherent cells were enzymatically detached by incubation for two minutes in 
Trypsin-EDTA solution at 37°C. Cells were centrifuged at 1000 g for three minutes, resuspended in 
fresh medium, counted and seeded for experiments or sub-cultivation. Podocytes and Vero E6 cells 
were seeded at a density of 5,000 cells/cm2 and 10,000 cells/cm2, respectively.  
 
2.2.1.2 Primary cells 
Primary podocytes were maintained in RPMI medium supplemented with 10% FCS and 1% ITS. 
HREPCs were cultured in renal epithelial cell growth medium-2. Primary cells were only used for 
experiments from passages two to six. Cells were sub-cultivated and seeded for experiments at a 
confluence of 70-80% by using the DetachKit for primary cells according to the manufacturer’s 
protocol for detachment. Primary podocytes and HREPCs were centrifuged at 200 g for three 
minutes, resuspended in fresh medium, counted and seeded at a density of 5,000 cells/cm2 and 
15,000 cells/cm2, respectively.  
 
2.2.2 Human serum and tissue samples 
Patients with serologically-confirmed acute hantavirus infection and healthy volunteers were 
included in this study. Clinical data were collected through a review of medical charts from the 
Section of Nephrology (University of Heidelberg, Germany). This study was approved by the Ethics 
Committee of the University of Heidelberg and it adhered to the Declaration of Helsinki. Written 
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informed consent was obtained from all participants. Human serum samples of three healthy 
volunteers were donated and, in addition, samples of three hantavirus-infected patients were 
obtained during clinical routine. Samples were collected in S-Monovettes (Sarstedt, Nümbrecht, 
Germany) with clotting activators and centrifuged at 2000 g for seven minutes to remove 
erythrocytes and clotting factors. Sera were aliquoted and stored at -80°C. Before usage in cell 
culture experiments, samples were heated at 56°C for 30 minutes. Specimens of renal biopsies of 
three patients with serologically-confirmed PUUV infection and specimens of a healthy kidney from 
living donor were fixed in glutaraldehyde and embedded in Epon-Araldite after post-fixation with 
osmium tetroxide. Fixed specimens were cut in ultra-thin sections of <100 nm and loaded on 
electron microscopy grids. Prepared samples were analyzed by transmission electron microscopy 
(JEM-1400, Jeol, Freising, Germany). Sample preparation and electron microscopy analysis were 
performed at the Institute of Pathology (University of Heidelberg, Germany). 
 
2.2.3 Virus propagation and infection  
HTNV and PUUV were propagated on Vero E6 cells. For the production of viral stocks, cells were 
infected with a multiplicity of infection (MOI) of 1 for three hours followed by a medium exchange. 
After 5 days, cell culture supernatants were collected, centrifuged to remove cell debris, aliquoted 
and stored at -80°C. The amount of infectious particles in the respective stocks was analyzed by 
titration assay on Vero E6 cells in triplicates. Therefore, cells were inoculated with 1, 5, 10 and 50 µl 
of collected virus-containing supernatants and the amount of infectious particles was determined by 
measuring the infected cells two days post infection (dpi) by immunofluorescence.  
For infection during experiments, culture medium was reduced to 50% and cells were inoculated 
with respective viral stocks. Virus inoculum of HTNV or PUUV at a MOI of 1 was added to the cells. 
After three hours, medium was exchanged to remove unbound virus and cells were incubated in 
fresh medium for the indicated points of time. Experiments with PUUV and HTNV were performed 
under biosafety level 2 and 3 (University of Heidelberg, Germany) conditions, respectively. 
 
2.2.4 Immunofluorescence 
Cells grown on cover slips from in vitro experiments were fixed with fixation solution for ten minutes. 
Cells were further incubated with quenching buffer for four minutes and, after PBS washing, with 
permeabilization solution for two minutes. Cells were stained in a humidified chamber with primary 
antibodies and after washing with fluorescently-labeled secondary antibodies for one hour each. 
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Antibody concentrations were diluted in blocking solution (see chapter 2.1.4 for dilutions). Hoechst 
33342 (3.2 µM, Thermo Fisher Scientific, Waltham, USA) for cell nuclei and Alexa Fluor-488 phalloidin 
(6.6 µM Thermo Fisher Scientific, Waltham, USA) for F-actin staining were incubated together with 
secondary antibodies. After staining, cells were washed with PBS and deionized water and afterwards 
mounted head-down on microscope glass slides by covering in mounting media. Fluorescence 
microscopy analysis was performed with the Observer D1 with an Axiocam 506 mono camera (Carl 
Zeiss, Jena, Germany). The TE-2000 microscope with a Hamamatsu EMCCD camera (Nikon, Tokyo, 
Japan) was used for confocal analysis.  
 
2.2.5 Analysis of amount of infection, N protein pattern and N protein expression level 
The amount of infected cells was determined via fluorescence microscopy by staining cells for nuclei 
and hantaviral N protein. Per approach, ten randomly-selected fields at a magnification of x100 were 
recorded. Cells showing N protein expression were determined as positive for infection. Uninfected 
and infected cells were counted and the amount of infected cells was defined in percent.  
A total of 100 randomly-selected infected cells were analyzed for the cellular localization of N protein 
by fluorescence microscopy. N protein expression was distinguished by a punctuate and a 
filamentous-like distribution. Cells were positive for a filamentous pattern by detecting at least one N 
protein fiber-like structure.  
The expression level of N proteins was determined by analysis of 100 randomly-selected transfected 
cells that were stained for N proteins. The fluorescence levels were calculated with ImageJ as total 
corrected cell fluorescence (TCCF) of N protein (TCCF = integrated density – (area of selected cell × 
mean background fluorescence)) [117, 118]. 
 
2.2.6 Viability assay 
The number of viable cells was determined by quantification of the ATP amount according to the 
manufacturer’s protocol of the CellTiter-Glo Luminescent Cell Viability Assay (Promega, Fitchburg, 
USA). In brief, cells were grown in opaque-walled 96-well plates (Greiner Bio-One, Kremsmünster, 
Austria), inoculated with hantaviruses as described above and lysed with a luciferase-containing 
buffer at indicated points of time. Thereby, the intracellular amount of ATP is directly proportional to 
the number of cells. The luminescent signal of the luciferase reaction was recorded by the Glomax 
  
Material & Methods 20 
microplate reader (Promega, Fitchburg, USA). Viability of infected cells was assessed in 
quadruplicates and compared to uninfected control cells.  
2.2.7 Effects of cytoskeletal drugs on N protein localization and hantaviral release 
In each experiment, cells were inoculated with hantaviruses in triplicates for six days. Cells were 
washed three times with medium to remove remaining viral particles and incubated with fresh 
medium for four hours as reference for viral release. For treatment, cells were washed and incubated 
with fresh medium for four hours supplemented with either DMSO solvent control or cytoskeletal 
depolymerization inhibitors. Podocytes were incubated with 1 µM Cyto D and 10 µM NOC whereas 
Vero E6 cells were treated with 8 µM Cyto D and 10 µM NOC. Again, for recovery, cells were washed 
and incubated with normal medium for another four hours. Supernatants were harvested after 
reference, treatment, and recovery phase, centrifuged at 1000 g for three minutes to remove cell 
debris and stored at -80°C. The amount of infectious viral particles in the supernatants was 
determined by In-Cell Western assay.Cells on coverslips were fixed after treatment and recovery 
phase and stained for hantaviral N protein and for either F-actin or tubulin.  
 
2.2.8 In-Cell Western assay 
Vero E6 cells on opaque-walled 96-well plates were inoculated with equal amounts of virus-
containing supernatants in triplicates and medium was exchanged after three hours. Cells were fixed 
at two days post infection, quenched and permeabilized as described above for 
immunofluorescence. After incubation of 30 minutes in blocking solution, cells were stained with 
primary antibodies against N protein and respective near-infrared fluorescence-conjugated 
secondary antibodies for one hour each (see chapter 2.1.4 for antibody dilutions). Nuclei were 
stained for cell number normalization with DRAQ5/Sapphire according to the manufacturer’s 
protocol together with secondary antibodies. After staining, cells were washed three times with PBST 
for ten minutes and once with deionized water. The plate was turned upside down and blotted 
gently on paper towels to remove remaining solution. Cells were scanned by the Odyssey Imaging 
System (LI-COR, Lincoln, USA) and quantification of infection was performed using the Image Studio 
software with the In-Cell Western module.  
 
2.2.9 Quantification of cellular actin forms 
The ratio of intracellular filamentous (F-) and globular (G-) actin was quantified according to the 
manufacturer’s protocol of the G-actin/F-actin In Vivo Assay Kit (Cytoskeleton Inc, Denver, USA). 
  
Material & Methods 21 
Briefly, uninfected or hantavirus-infected cells were lysed at six days post infection in a detergent-
based buffer that maintains F- and G-actin pools. After an ultracentrifugation step at 100,000 g for 
one hour at 37°C, soluble G-actin is found in the supernatant, whereas insoluble F-actin was pelleted. 
To control an effective fractionation, uninfected control cells were treated with the actin-
polymerization drug phalloidin, which resulted in the accumulation of actin in the insoluble pelletized 
fraction. G-actin-containing supernatants were harvested. Pellets were resuspended in the same 
volume in depolymerization buffer to dissociate F-actin and incubated for one hour. All samples were 
diluted with the supplied 5x SDS lysis buffer and analyzed by Western blot.  
 
2.2.10 Western blot analysis 
Protein samples in SDS lysis buffer were loaded on a 12% polyacrylamide gel and separated by 
electrophoresis at 120 V in SDS running buffer by the Mini-PROTEAN Tetra Cell System (Bio-Rad, 
Munich, Germany). The PageRuler Plus Prestained Protein Ladder (Thermo Fisher Scientific, 
Waltham, USA) was used to determine protein size. Separated proteins were blotted from the gel 
onto nitrocellulose membranes (GE Healthcare, Little Chalfont, UK) enclosed between Whatman 
papers (GE Healthcare, Little Chalfont, UK) in the Tetra Blotting Module (Bio-Rad, Munich, Germany) 
for one hour at 1.57 mA/cm2 in blotting buffer. After transfer, membranes were incubated in milk 
blocking solution for 30 minutes. Proteins were stained with indicated primary antibodies and, after 
a triple washing step with PBST for ten minutes each, with near-infrared fluorescence-conjugated 
secondary antibodies for one hour each. Antibodies were diluted in milk blocking solution as 
described in chapter 2.1.4. After additional washing steps, membranes were scanned by the Odyssey 
Clx Imaging System. Multiple proteins on the same blot were distinguished by staining with different 
secondary antibodies which emit after excitation in either the 700 nm or 800 nm channel. 
Quantitative image analysis was performed by using the Image Studio software. 
 
2.2.11 Adhesion assay 
Uninfected and hantavirus-infected cells were detached at day six post infection by Trypsin-EDTA 
solution, centrifuged and counted as described above. A total of 1x104 cells of a single-cell 
suspension were added in quadruplicates per approach in each well of an opaque-walled 96-well 
plate. Cells were left to adhere in equal volumes for one hour at 37°C and subsequently washed 
three times with PBS and fixed with fixation solution. The amount of adhered cells was quantified by 
In-Cell Western assay. 
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2.2.12 UV irradiation and depletion of viral particles containing supernatants 
Infectious viral particles in supernatants derived from hantavirus-infected podocytes were either 
inactivated by UV irradiation or depleted. For UV irradiation, supernatants were transferred to a 
culture medium plate with lid opened and placed into the Stratalinker 1800 UV-transilluminator 
(Agilent, Santa Clara, USA). Infectious particles were inactivated with the energy of 1.4 J/cm2. For 
virus depletion, supernatants were loaded into centrifugal filter devices equipped with an Omega 
membrane 300k (Pall, New York, USA) with a molecular weight cut-off of 300 kilodalton (kDa) and 
centrifuged at 5,000 g until complete filtration. A portion of supernatants were diluted in 6x cell lysis 
buffer and analyzed for the presence of N proteins by Western blot. The presence of infectious 
particles was examined by inoculation of Vero E6 cells and immunofluorescence analysis of N 
protein.  
 
2.2.13 Migration assay 
Cells were seeded into 2-well µ-dishes (Ibidi, Martinsried, Germany) with a detachable insert defining 
a cell-free gap and inoculated with hantaviruses. The insert was removed at six days post infection to 
allow cell migration. The cell-free gap was imaged immediately after insert removal and after eight 
hours by JuLI Smart Fluorescence Cell Imager (Bulldog-Bio, Portsmouth, USA). In case of Vero E6 cells, 
the culture medium was supplemented with mitomycin C (50 µg/ml, Sigma-Aldrich, St. Louis, USA) to 
exclude cell proliferation. Cell migration was determined by calculation of the covered distance 
between beginning and end of each experiment. To monitor the infection, cells were stained for 
nuclei and hantaviral N protein by immunofluorescence as described above. For the analysis of 
possible soluble factors in supernatants or human sera causing changes in migration, uninfected cells 
in 2-well µ-dishes were incubated 30 minutes prior insert removal with either supernatants of 
infected cells or 50% human sera in normal culture medium. 
 
2.2.14 Plasmid preparation 
Bacteria (strain DH5α) were made competent according to the Roti-Transform protocol and used for 
propagation of plasmids encoding for maxGFP, HTNV N, or PUUV N protein. About 2.5x105 
competent cells were incubated with 1 µg of plasmid DNA for 30 minutes on ice. After a heat-shock 
of 42°C for 45 seconds, cells were immediately rested on ice for 15 minutes. Cells were pre-incubated 
in LB medium (BD, Franklin Lakes, USA) for 45 minutes at 37°C prior to cultivation in overnight 
approaches in LB medium containing respective antibiotics (0.287 mM ampicillin or 0.006 mM 
kanamycin). Plasmids from overnight cultures were harvested according to the EndoFree Plasmid 
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Maxi Kit protocol (Qiagen, Venlo, Netherland). Plasmid DNA was dissolved in endotoxin-free water 
and concentration was determined by measuring the absorbance at 260 nm in the photometer 
before storage at -20°C.  
 
2.2.15 Transfection of podocytes 
Podocytes were transfected by nucleofection according to the manufacturer’s protocol of the Amaxa 
Basic Nucleofector Kit for Primary Mammalian Epithelial Cells (Lonza, Basel, Switzerland). Briefly, 
differentiated podocytes at 70-80% confluency were detached. A total of 1x106 cells were 
resuspendend in nucleofector solution VPI-1005 and incubated with 1 µg plasmid DNA encoding for 
maxGFP, HTNV N, and PUUV N protein or with empty vectors. The suspension was transferred to 
electrode cuvettes and transfection was performed with the T-013 program of the Nucleofecter 2b 
device (Lonza, Basel, Switzerland). To enhance the transfection efficacy, cells in cuvettes were rested 
for ten minutes, followed by resuspension in pre-warmed medium and transfer to appropriate 
culture dishes. After eight hours cells were washed with media and subjected to live cell imaging or 
immunofluorescence.  
 
2.2.16 Live cell imaging 
Uninfected and infected podocytes were detached, centrifuged, and counted as described above. A 
total of 5x104 cells were seeded on μ-slide 2-wells (Ibidi, Martinsried, Germany) and left to adhere for 
two hours. After a triple wash with culture medium, cells were monitored every 10 minutes for eight 
hours by the JuLI Smart Fluorescence Cell Imager (Bulldog-Bio, Portsmouth, USA). Podocytes were 
tracked by the ImageJ manual tracking plugin. The covered distances of single cells were analyzed by 
using the chemotaxis tool plugin. The migration of podocytes on μ-slide 2-wells co-transfected with 
plasmids encoding for N protein and maxGFP were monitored by using the Ti-HCS microscope 
(Nikon, Tokyo, Japan). Images were recorded every ten minutes for eight hours. Cells expressing 
maxGFP were tracked and analyzed as described above for infected cells.  
 
2.2.17 Statistical analysis 
Data analysis was performed by using Prism 6.0. The Kolmogorov-Smirnov test was applied to test for 
normal distribution of values and, furthermore, the significance level of two groups was measured by 
two-tailed Student’s t-test. P values of ≤ 0.05 were considered significant. *P ≤ 0.05; **P ≤ 0.01; ***P 
≤ 0.001; ****P ≤ 0.0001; ns: not significant. 
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3. Results 
3.1 Analysis of hantaviral infection in glomerular structures 
3.1.1 Glomerular alterations in kidney biopsy specimens of hantavirus patients  
The clinical picture of an Old World hantavirus infection is characterized by an acute kidney failure 
with non-selective proteinuria indicating that cells of the glomerulus are affected. In order to study 
the underlying mechanism of disease, renal biopsies of three patients with serologically-confirmed 
acute hantavirus infection and of one healthy control person were analyzed by electron microscopy 
for changes in glomerular structures. All patients presented characteristics of hantavirus infection 
with an initial sudden onset of flu-like symptoms. During the clinical course, patients showed an 
impairment of laboratory blood parameters such as thrombocytopenia, rise in levels of serum 
creatinine, leucocytes, LDH, CRP and low levels of serum albumin (Tab. 2). In all three patients, 
electron microscopy analysis of glomeruli between day seven and 13 after onset of symptoms 
revealed changes of important structures, which maintain the blood-urine filtration barrier (Fig. 4). 
Compared to the control biopsy, the diameter of the glomerular basement membrane was mildly 
thickened without accumulation of immune complexes. The overlaying podocytes showed the most 
severe structural alterations. Cells were enlarged, vacuolated and their FPs were focally effaced. 
The analysis of biopsies show that podocytes, which are crucial for the renal filtration, are affected 
during hantavirus disease as displayed by a loss of proper FPs. Therefore, the effects of hantavirus 
infection on podocytes was further examined in vitro. 
 
 
Table 2 Characteristics, peak, and nadir levels of laboratory parameters obtained from three patients with 
acute PUUV hantavirus disease used for electron microscopy analysis of glomeruli. 
Characteristic #19 #64 #131 reference 
Age (yr) 48 37 39 - 
Gender m m m - 
Duration of hospitalization (days) 6 8 9 - 
Max serum creatinine level (mg/dl) 8.35 11.94 5.33 0.1-1.3 
Min serum albumin level (g/liter) 32.9 28 33.3 30-50 
Max leukocyte count (G/liter) 11.12 15.6 19.91 4-10 
Min platelet count (G/liter) 75 65 37 150-440 
Max LDH
a
 activity (U/liter) 335 329 540 < 248 
Max CRP
b
 level (mg/liter) 51.1 94.5 127.6 < 5 
Point of renal biopsy (dpo
c
) 13 9 7 - 
a
LDH: lactate dehydrogenase, 
b
CRP: C-reactive protein, 
c
dpo: days post onset 
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Figure 4 Electron microscopy of human glomeruli. Renal biopsy specimens of three patients with acute 
hantavirus disease and one of a healthy control kidney were analyzed by transmission electron microscopy. 
Arrowheads indicate intact foot processes of podocytes. Arrows show effacement of podocyte foot processes. 
CL: capillary lumen; En: endothelium; P: podocyte; GBM: glomerular basement membrane; RBC: red blood cell; 
V: vacuole. 
 
3.1.2 In vitro effects of hantavirus infection on podocytes 
3.1.2.1 Localization of hantaviral N protein in podocytes 
The electron microscopy studies demonstrated that foot processes of podocytes were effaced during 
hantavirus disease. The integrity of proper foot processes is mainly maintained by the cytoskeleton. 
Therefore, a possible involvement of the cytoskeleton components actin and microtubules was 
analyzed in human podocytes in vitro (Fig. 5).  
First, the localization of the hantaviral N protein was examined. Infection of podocytes with HTNV 
revealed that the N protein appears in a punctate and a filamentous distribution (Fig. 5A). The 
amount of cells showing the filamentous pattern increased during infection to a maximum of 42.03% 
± 0.97% (Fig. 5C). Moreover, confocal microscopy analysis revealed that the filamentous N protein 
pattern partially co-localized with F-actin as displayed by the histogram showing the fluorescence 
intensities of both proteins. In contrast, no co-localization was observed between HTNV N protein 
and microtubules (Fig. 5A). In order to investigate if this localization is exhibited by other Old World 
hantaviruses as well, the infection of podocytes with the less pathogenic PUUV was analyzed for the 
described effects (Fig. 5B and D). The amount of filamentous PUUV N protein co-localizing with F-
actin considerably differed compared to HTNV and was only observed in a maximum of 7.62% ± 
2.26% of infected cells. Even the co-localization of F-actin and PUUV N protein was less distinctive 
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than for HTNV N protein. An association between PUUV N protein and microtubules was not 
detected. The infection kinetics of both virus species were comparable, indicating that the disparity 
in the appearance and localization of N proteins were not due to different infection rates (Fig. 5C and 
D).  
 
Figure 5 Localization of HTNV and PUUV N protein in podocytes. (A and B) Podocytes infected with HTNV (A) 
and PUUV (B) were analyzed for N protein, F-actin, and tubulin localization by confocal microscopy on day six 
after infection. The histogram shows the fluorescence intensity profiles of F-actin (green), tubulin (green), and 
N protein (red) stainings along the indicated lines. Cells were imaged at a magnification of ×1000. (C and D) 
Podocytes were analyzed for the N protein localization pattern (left y-axis) and infection (right y-axis) of HTNV 
(C) and PUUV (D) at indicated points of time. Data were obtained from three independent experiments. Shown 
is mean ± SD. 
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3.1.2.2 Effects of cytoskeletal polymerization inhibitors on N protein in podocytes  
In order to examine if an intact cytoskeleton is a prerequisite for the filamentous N protein pattern, 
hantavirus-infected podocytes were treated with inhibitors of cytoskeleton polymerization (Fig. 6 
and 7). Cytochalasin D was used for actin filament disruption and nocodazole for depolymerization of 
microtubules. The drug concentrations were adjusted to an adequate concentration, which 
efficiently inhibited the polymerization of the cytoskeleton structures without any cytopathic effect, 
as revealed by measurement of the cell viability after treatment (Fig. 6 and 7).  
The inhibition of actin polymerization in HTNV- and PUUV-infected podocytes significantly resulted in 
the disappearance of almost the entire filamentous N protein pattern (Fig. 7A-D). Moreover, it seems 
that N proteins of both virus species were re-located into perinuclear regions (Fig. 7A and C). 
Interestingly, after washout of the inhibitors the N protein pattern ratio between punctate and 
filamentous distribution was completely restored compared to control cells. In contrast, the 
depolymerization of microtubules had neither an effect on the localization nor on the filamentous N 
protein structures.  
These results indicate that an intact integrity of the actin cytoskeleton is crucial for the filamentous N 
protein distribution. 
 
 
 
Figure 6 Cell viability of podocytes after treatment with inhibitors of cytoskeletal polymerization. Uninfected 
cells were treated with solvent control (DMSO), nocodazole (NOC), or cytochalasin D (CytoD) and viability was 
assessed. The viability of untreated cells was set to 100%. Three independent experiments were performed in 
triplicates. Shown is mean ± SD. 
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Figure 7 Localization of N proteins in podocytes after modulation of the cytoskeleton. (A and C) Podocytes 
were infected with HTNV (A) and PUUV (C) and treated with solvent control (DMSO), cytochalasin D (Cyto D), or 
nocodazole (NOC) on day six post infection. Localization of N protein, F-actin, and tubulin was analyzed after 
drug treatment (treat) and after recovery (rec) by fluorescence microscopy. Cells were imaged at a 
magnification of ×1000. (B and D) The localization pattern of N protein of 100 DMSO- and drug-treated 
podocytes was quantified in each experiment. Three independent experiments were performed. Shown is 
mean ± SD.  
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3.1.2.3 Effects of cytoskeletal polymerization inhibitors on viral release of podocytes 
The role of cytoskeleton components was further analyzed regarding the hantaviral replication cycle. 
To investigate the importance of F-actin and microtubules for the release of infectious particles, 
hantavirus-infected podocytes were treated with cytochalasin D, nocodazole or solvent control (Fig. 
8). Supernatants were harvested four hours after treatment with cytoskeleton polymerization 
inhibitors because this was the earliest point of time to reproducibly obtain supernatants with 
detectable amounts of infectious particles.  
Interestingly, the disruption of the cytoskeleton components caused different consequences for both 
virus species (Fig. 8A). Nocodazole had a similar reducing effect on the viral release of HTNV- (81.05% 
± 4.73% vs. 100% ± 11.91%, P = 0.0108) and PUUV-infected podocytes (75.81% ± 6.93% vs. 100% ± 
9.15%, P = 0.0003) compared to control cells. The amount of infectious particles found in the 
supernatants after cytochalasin D treatment differed enormously. After F-actin disruption, the viral 
release of HTNV-infected cells was significantly decreased compared to untreated cells (53.84% ± 
8.50% vs. 100% ± 11.91%, P >0.0001). In contrast, depolymerization of actin had no significant effect 
on the release of PUUV particles (110.13% ± 6.70% vs. 100% ± 9.15%, P = 0.0543). After washout of 
the inhibitors, viral release of both viruses was completely restored compared to controls as 
determined by subsequent analysis of supernatants four hours later (Fig. 8B). 
These data indicate that hantaviruses depend on microtubules for an efficient release of infectious 
particles. In addition, the viral release of HTNV is also dependent on an intact actin cytoskeleton. The 
data suggest a correlation between F-actin localization of N protein and the release of hantaviruses. 
 
 
 
Figure 8 Viral release assay of HTNV- and PUUV-infected podocytes. Podocytes were infected with HTNV or 
PUUV and treated with solvent control (DMSO), cytochalasin D (Cyto D), or nocodazole (NOC) on day six post 
infection for four hours. (A) Supernatants of treated cells were harvested and the amount of infectious 
particles was quantified by In-Cell Western. Three independent experiments were performed in triplicates. The 
viral release of solvent control-treated cells was set to 100%. Shown is mean ± SD. (B) Cells were washed after 
treatment and incubated for another four hours in fresh medium. The amount of released viral particles was 
quantified as described above. 
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3.1.2.4 Hantaviral effects on actin cytoskeletal organization of podocytes 
Crucial for podocyte function and FP formation is an intact actin cytoskeleton. The results displayed 
above revealed FP effacement during hantavirus disease and an involvement of actin during the viral 
replication cycle. Therefore, changes of the actin cytoskeleton after hantavirus infection were 
examined by quantifying the amount of F- and G-actin in infected and uninfected podocytes (Fig. 9). 
At first, any cytopathic effect after infection leading to a loss of cells was excluded by measuring the 
cell viability. Neither HTNV nor PUUV caused any effect on the viability of podocytes (Fig. 9A and C). 
Uninfected, hantavirus-infected, and phalloidin-treated podocytes were lysed and cellular fractions 
were analyzed for cellular actin forms (Fig. 9B and D). The F-actin enhancer phalloidin, which drives 
actin polymerization to more than 80%, served as positive control and demonstrated an effective 
pelleting of F-actin. Cellular fractionation of podocytes revealed that the amount of F-actin in the 
insoluble fraction of HTNV-infected cells was decreased and the F-/G- ratio was significantly changed 
compared to control cells (0.45 ± 0.09 vs. 1.00 ± 0.14, P = 0.0045) (Fig. 9B). The cytoskeletal 
organization was also influenced by PUUV, but to a lower extent. Compared to control cells, the F-/G-
actin ratio of PUUV-infected podocytes was reduced to 0.67 ± 0.12 vs. 1.00 ± 0.11, P = 0.0245 (Fig. 
9D). 
These results show that an infection with hantaviruses changes the actin cytoskeleton in podocytes 
by decreasing the F-actin amount.  
 
3.1.2.5 Functional consequences of hantavirus infection in podocytes 
Since the hantaviral N protein is associated with F-actin and its amount is decreased after infection, it 
could be possible that these interactions cause consequences for podocyte function. Therefore, the 
migration and adhesion, which are crucial for proper podocyte function, were examined.  
First, the adhesion capacity of podocytes was analyzed after infection with hantaviruses and 
compared to uninfected control cells (Fig. 10A and B). The infection was monitored by 
immunostaining for hantaviral N protein revealing that more than 90% of cells were positive for 
HTNV or PUUV N protein. The amount of HTNV-infected podocytes that adhered after detachment 
was decreased to 57.13% ± 16.28% vs. 100% ± 15.7%, P = 0.0304 (Fig. 10A). The effect of PUUV was 
less pronounced and the adhesion ability was reduced to 70.96 % ± 7.88% vs. 100% ± 15.53%, P = 
0.0446 (Fig. 10B).  
Next, the migration capacity was analyzed by investigating podocyte motility into a cell-free gap. The 
area covered by podocytes was measured at the beginning and the end of each experiment (Fig. 10C 
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and D). The infection of HTNV and PUUV caused an impaired migration of podocytes compared to 
uninfected cells. The migration was reduced to 27.49% ± 10.69% vs. 100% ± 9.29%, P = 0.0009 for 
HTNV and to 72.80% ± 4.89% vs. 100% ± 11.06%, P = 0.0041 for PUUV. Immunostaining of N proteins 
revealed that more than 90% of podocytes were infected. 
In summary, hantaviruses are capable to cause functional consequences in podocytes by reducing 
the adhesion and migration capacity. The effects are more pronounced for HTNV than PUUV 
infection. 
 
 
 
 
Figure 9 Cytoskeletal organization in HTNV- and PUUV-infected podocytes. (A and C) Podocytes were infected 
with HTNV (A) or PUUV (C) and viability was assessed on day six after infection. Control cells remained 
uninfected and viability was set to 100%. Three independent experiments were performed in triplicates. Shown 
is mean ± SD. (B and D) Fractionated cellular lysates (SN: supernatant, P: pellet) of uninfected (control), HTNV- 
(B) or PUUV (D)-infected, and phalloidin-treated podocytes were analyzed for actin and N protein by Western 
blot on day six after infection. One representative Western blot taken out of three independent experiments is 
displayed. The band intensities from Western blots were quantified to measure the F-/G-actin ratio. The ratio 
of uninfected podocytes was set to 1. Shown is mean ± SD. 
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Figure 10 Adhesion and migration capacity of HTNV- and PUUV-infected podocytes. (A and B) Uninfected and 
HTNV-(A) or PUUV-(B) infected podocytes were detached, plated into 96-wells and numbers of attached cells 
were quantified after one hour by In-Cell Western. Three independent experiments were performed in 
quadruplicates. N protein was stained in red and cells were imaged at a magnification of ×200. Adhesion of 
uninfected cells was set to 100%. Shown is mean ± SD. (C and D) Confluent monolayers of podocytes were 
seeded into µ-plates and infected with HTNV (C) or PUUV (D). After removal of the insert and after eight hours, 
cell-free areas were measured and relative migration was calculated. Migration of uninfected podocytes was 
set to 100%. N protein was stained in red and cells were imaged at a magnification of ×100. Representative 
images taken out of three independent experiments are displayed. Shown is mean ± SD. 
 
3.1.3 In vitro effects of hantavirus infection on Vero E6 cells 
3.1.3.1 Localization of hantaviral N protein in Vero E6 cells 
Vero E6 cells are renal epithelial cells from the African green monkey that are commonly used for 
virus propagation and most of the previous studies on hantaviruses were performed using these 
cells. Thus, Vero E6 cells were included in this study to analyze possible cell-specific effects after 
hantavirus infection (Fig. 11). 
The N protein appearance in Vero E6 cells differed enormously from that found in podocytes (see Fig. 
11 and Fig. 5). Vero E6 cells infected with either HTNV or PUUV showed no detectable filamentous N 
protein. The N protein of both virus species was strictly localized in the punctate pattern during the 
infection (Fig. 11A-D). Moreover, the N protein co-localization with actin, found in podocytes, was 
absent in hantavirus-infected Vero E6 cells. Again, no association with the microtubules was 
observed.  
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The results show that the filamentous pattern of N protein and the co-localization with actin can only 
be observed in human podocytes. 
 
3.1.3.2 Effects of cytoskeletal polymerization inhibitors on viral release of Vero E6 cells 
Previous studies of the hantaviral replication cycle in Vero E6 cells showed a different involvement of 
cytoskeletal components depending on the virus species used. Despite the fact that no co-
localization was found, Vero E6 cells were examined on whether or not the release of viruses is 
dependent on the actin cytoskeleton. 
Cytochalasin D and nocodazole inhibited efficiently the polymerization of actin and microtubules in 
Vero E6 cells, respectively (Fig. 12A). After treatment, both depolymerization inhibitors had no 
influence on the cell viability, indicating that possible effects were not caused by cell death (Fig. 12B).  
The disruption of the cytoskeleton components in HTNV-infected Vero E6 cells showed different 
results as seen for HTNV-infected podocytes (Fig. 12C and Fig. 8A). Compared to untreated cells, the 
depolymerization of microtubules caused a massive decrease of released HTNV particles to 9.86% ± 
6.04% vs. 100% ± 12.36%, P < 0.0001. In contrast to podocytes, a deteriorated actin cytoskeleton had 
no effect on the viral release in HTNV-infected Vero E6 cells. The effects on PUUV-infected Vero E6 
cells were similar to that and the disruption of microtubules decreased the release of infectious 
particles compared to controls to 17.73% ± 5.09% vs. 100% ± 15.01%, P < 0.0001, while actin 
depolymerization had no consequences (Fig. 12C). As already shown in podocytes, the effect on the 
viral release was reversible after washout of the respective polymerization inhibitors in Vero E6 cells 
(Fig. 12D).  
These data indicate that microtubules play a more important role in the release of hantavirus in Vero 
E6 cells than in podocytes. Moreover, the integrity of F-actin is only observed for HTNV localization 
and viral release in podocytes.  
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Figure 11 Localization of HTNV and PUUV N protein in Vero E6 cells. Vero E6 cells infected with HTNV (A) and 
PUUV (B) were analyzed for N protein, F-actin, and tubulin localization by confocal microscopy on day six after 
infection. The histogram shows the fluorescence intensity profiles of F-actin (green), tubulin (green), and N 
protein (red) stainings along the indicated lines. Cells were imaged at a magnification of ×1000. (C and D) Vero 
E6 cells were analyzed for the N protein localization pattern (left y-axis) and infection (right y-axis) of HTNV (C) 
and PUUV (D) at indicated points of time. Data were obtained from three independent experiments. Shown is 
mean ± SD. 
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Figure 12 Viral release assay of HTNV- and PUUV-infected Vero E6 cells. (A) Staining of F-actin and 
microtubules after treatment of uninfected Vero E6 cells with solvent control (DMSO), cytochalasin D (Cyto D), 
or nocodazole (NOC) for four hours. Representative images are displayed. (B) Viability of uninfected Vero E6 
cells after treatment was assessed. The viability of untreated cells was set to 100%. Three independent 
experiments were performed in triplicates. Shown is mean ± SD. (C and D) Vero E6 cells were infected with 
HTNV or PUUV and treated with solvent control (DMSO), cytochalasin D (Cyto D), or nocodazole (NOC) on day 
six post infection for four hours. (C) Supernatants of treated cells infected with HTNV or PUUV were harvested 
and the amount of infectious particles was quantified by In-Cell Western. Three independent experiments were 
performed in triplicates. The viral release of solvent control-treated cells was set to 100%. Shown is mean ± SD. 
(D) Cells were washed after treatment and incubated for another four hours in fresh medium. The amount of 
released viral particles was quantified as described above. 
 
3.1.3.3 Hantaviral effects on the actin cytoskeletal organization of Vero E6 cells 
The examined Old World hantaviruses did neither co-localize with F-actin nor depend on its integrity 
for viral release in Vero E6 cells. To determine if hantaviruses still have an effect on the organization 
of the actin cytoskeleton, the F-/G-actin ratio was also quantified in HTNV- and PUUV-infected Vero 
E6 cells (Fig. 13).  
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Vero E6 cells infected with neither HTNV nor PUUV affected the viability compared to uninfected 
cells (Fig. 13A and C). Moreover, both virus species did not significantly alter the F-/G-actin ratio in 
Vero E6 cells (Fig. 13B and D).  
 
 
Figure 13 Cytoskeletal organization in HTNV- and PUUV-infected Vero E6 cells. (A and C) Vero E6 cells were 
infected with HTNV (A) or PUUV (C) and viability was assessed at day six after infection. Control cells remained 
uninfected and viability was set to 100%. Three independent experiments were performed in triplicates. Shown 
is mean ± SD. (B and D) Fractionated cellular lysates (SN: supernatant, P: pellet) of uninfected (control), HTNV- 
(B) or PUUV (D)-infected, and phalloidin-treated Vero E6 cells were analyzed for actin and N protein by 
Western blot. One representative Western blot taken out of three independent experiments is displayed. The 
band intensities from Western blots were quantified to measure the F-/G-actin ratio. The ratio of uninfected 
Vero E6 cells was set to 1. Shown is mean ± SD. 
 
 
3.1.3.4 Functional consequences of hantavirus infection in Vero E6 cells 
The localization of hantaviral N protein and the effects of infection on F-actin differed enormously 
between Vero E6 cells and podocytes. To investigate, if hantaviruses are capable to cause functional 
consequences without an actin involvement, Vero E6 cells were also analyzed for adhesion and 
migration to examine cell-specific effects (Fig. 14).  
Visualization of N protein during experiments showed that more than 90% of the cells were infected 
(Fig. 14A-D). The functional assays revealed that neither HTNV nor PUUV were capable to induce 
impairment of the adhesion or migration of Vero E6 cells compared to control cells.  
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The different localization of N protein, the absence of actin involvement for viral release and the lack 
of functional consequences after hantavirus infection in Vero E6 cells demonstrate that the 
hantaviral replication cycle and subsequent cellular impairments vary tremendously in Vero E6 cells 
and podocytes.  
 
 
 
Figure 14 Adhesion and migration capacity of HTNV- and PUUV-infected Vero E6 cells. (A and B) Uninfected 
and HTNV-(A) or PUUV-infected (B) Vero E6 cells were detached, plated into 96-wells and numbers of attached 
cells were quantified after one hour by In-Cell Western. Three independent experiments were performed in 
quadruplicates. N protein was stained in red and cells were imaged at a magnification of ×200. Adhesion of 
uninfected cells was set to 100%. Shown is mean ± SD. (C and D) Uninfected or HTNV-(C) or PUUV-infected (D) 
Vero E6 were seeded confluently into µ-plates. After removal of the insert and after eight hours, cell-free areas 
were measured and relative migration was calculated. Migration of uninfected Vero E6 cells was set to 100%. N 
protein was stained in red and cells were imaged at a magnification of ×100. Representative images taken out 
of three independent experiments are displayed. Shown is mean ± SD. 
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3.1.4 Effects of hantaviruses on primary human podocytes 
3.1.4.1 Localization of hantaviral N protein in primary podocytes 
The observed effects in cell lines caused by hantaviruses were further analyzed focusing on their 
biological significance by analyzing primary human podocytes as relevant target cells (Fig. 15).  
The cells were first analyzed regarding the expression of podocyte-specific synaptopodin (Fig. 15A). 
Synaptopodin was found in the typical dotted filamentous-like distribution throughout the entirety of 
the primary podocyte [119]. 
After HTNV infection, primary podocytes displayed the punctate and filamentous N protein 
distribution as seen in the cell line (Fig. 15B). The localization of the filamentous pattern revealed 
that HTNV N protein co-localized in primary cells with F-actin. The number of cells displaying the 
filamentous pattern increased during infection to 16.74% ± 3.71% (Fig. 15C). In contrast, no N protein 
filamentous distribution was found in PUUV-infected primary podocytes (Fig. 15B and D). The 
amount of cells infected with HTNV or PUUV differed dramatically. While 77.55% ± 3.76% of primary 
podocytes were infected with PUUV, only 14.48% ± 1.33 showed a HTNV infection.  
These results demonstrate that HTNV N protein co-localizes with F-actin and that primary podocytes 
are more permissive for PUUV than for HTNV infection in vitro.  
 
3.1.4.2 Functional consequences of hantavirus-infected primary podocytes 
The migration capacity of primary podocytes was also analyzed by the covered distance of single 
infected cells. Due to a low percentage of HTNV infection, the migration was only determined in 
PUUV-infected primary podocytes (Fig. 16).  
Compared to uninfected control cells, the migration capability of primary podocytes was significantly 
reduced after infection with PUUV (62.65% ± 6.38 vs 100% ± 6.65%, P = 0.0022).  
In conclusion, filamentous N protein and functional consequences of hantavirus infection are also 
detected in primary cells. These findings are comparable to the results obtained in the podocyte cell 
line. 
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Figure 15 Localization of HTNV and PUUV N protein in primary podocytes. (A) Analysis for the expression of 
synaptopodin (red) in primary podocytes by immunofluorescence at a magnification of ×600. (B) HTNV- and 
PUUV-infected cells were analyzed for N protein and F-actin localization by confocal microscopy on day nine 
after infection. The histogram shows the fluorescence intensity profiles of F-actin (green) and N protein (red) 
stainings along the indicated lines. Cells were imaged at a magnification of ×1000. (C and D) Primary podocytes 
were analyzed for the N protein localization pattern (left y-axis) and infection (right y-axis) of HTNV (C) and 
PUUV (D) at indicated points of time. Data were obtained from three independent experiments. Shown is mean 
± SD. 
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Figure 16 Migration capacity of PUUV-infected primary podocytes. Migration of uninfected and PUUV-
infected primary podocytes was examined by live cell imaging. 100 cells per experiment were analyzed by 
single-cell-tracking. Three independent experiments were performed. Shown is mean ± SD. 
 
 
3.2 Analysis of hantaviral infection in renal tubules 
3.2.1 Tubular alterations in kidney biopsy specimens of patients with hantavirus disease 
Previous studies showed that tubular epithelial cells are infected by hantaviruses in vivo and the non-
selective proteinuria during hantaviral disease indicates that the function of the tubular apparatus is 
disturbed. 
Renal biopsies of three patients with serologically-confirmed acute hantavirus infection and of one 
healthy control person were analyzed by electron microscopy for tubular changes between nine and 
13 days post onset (Tab. 3, Fig. 17). Compared to the control, biopsies of infected patients showed 
serious subcellular injuries. Hantavirus disease induced cell swelling and severe cytoplasmic 
vacuolization of the renal tubular epithelium. Vacuoles are mainly observed beneath the microvilli at 
the apical surface. Compared to control biopsies, damaged nuclei were found in biopsies of 
hantavirus-infected patients. The basement membrane and microvilli displayed a normal 
morphology.  
The analysis elucidates that, besides podocytes, tubular cells are also affected by hantaviruses, 
suggesting that their impairment might play a role during renal disease. The infection of hantaviruses 
in tubular epithelial cells was further analyzed in vitro.  
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Table 3 Characteristics, peak, and nadir levels of laboratory parameters obtained from three patients with 
acute PUUV hantavirus disease used for electron microscopy analysis of renal tubules. 
Characteristic #19 #36 #64 reference 
Age (yr) 48 51 37 - 
Gender m m m - 
Duration of hospitalization (days) 6 11 8 - 
Max serum creatinine level (mg/dl) 8.35 9.25 11.94 0.1-1.3 
Min serum albumin level (g/liter) 32.9 30.8 28 30-50 
Max leukocyte count (G/liter) 11.12 13.91 15.6 4-10 
Min platelet count (G/liter) 75 33 65 150-440 
Max LDHa activity (U/liter) 335 375 329 < 248 
Max CRPb level (mg/liter) 51.1 85.3 94.5 < 5 
Point of renal biopsy (dpoc) 13 11 9 - 
a
LDH: lactate dehydrogenase, 
b
CRP: C-reactive protein, 
c
dpo: days post onset 
 
 
3.2.2 Effects of hantaviruses on human renal epithelial primary cells (HREPC) 
3.2.2.1 Localization of hantaviral N protein in HREPC 
Electron microscopy analysis of renal biopsies revealed an alteration of tubular epithelial cell 
morphology during hantavirus disease. In order to investigate if functional consequences of 
hantavirus infection exists as in podocytes, the association of the hantaviral N protein to F-actin was 
analyzed in HREPC (Fig. 18).  
As for podocytes, infection of HREPC with HTNV displayed a punctate and filamentous pattern of the 
HTNV N protein. Analysis of the fluorescence intensities of HTNV N protein and F-actin revealed a co-
localization (Fig. 18A). The amount of cells showing filaments increased to a maximum of 42.16% ± 
1.70% (Fig. 18B). In contrast, the punctate pattern dominated in PUUV-infected HREPC and no 
filamentous pattern was observed (Fig. 18A and C). Interestingly, as seen in primary podocytes, 
HREPC were much more permissive for PUUV than for HTNV infection. The amount of PUUV-infected 
HREPC reached to 79.23% ± 6.247% while only 36.33% ± 2.10% of cells were infected with HTNV (Fig. 
18B and C).  
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Figure 17 Electron microscopy of human renal tubules. Renal biopsy specimens of three patients with acute 
hantavirus disease and one of a healthy control kidney were analyzed by transmission electron microscopy. 
MV: microvilli, BM: basement membrane, L: lumen, V: vacuole, N: nucleus. 
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Figure 18 Localization of HTNV and PUUV N protein in HREPC. (A) HREPC infected with HTNV or PUUV were 
analyzed for N protein and F-actin localization by confocal microscopy on day nine after infection. The 
histogram shows the fluorescence intensity profiles of F-actin (green) and N protein (red) staining along the 
indicated lines. Cells were imaged at a magnification of ×1000. (B and C) HREPC were analyzed for the N protein 
localization pattern (left y-axis) and infection (right y-axis) of HTNV (B) and PUUV (C) at indicated points of time. 
Data were obtained from three independent experiments. Shown is mean ± SD. 
 
3.2.2.2 Functional consequences of hantavirus-infected HREPC 
Since the adhesion and migration capacity is also of importance for HREPC, functional consequences 
after infection with HTNV and PUUV were examined (Fig. 19).  
In comparison to controls (100% ± 3.35%), the adhesion of PUUV- and HTNV-infected cells decreased 
to 60.83% ± 7.74%, P = 0.0097 and 82.56% ± 5.17%, P = 0.0474, respectively (Fig. 19A). The effect on 
the migration capacity of HREPC was also more severe after PUUV (58.63% ± 2.87%, P = 0.0006) than 
after HTNV infection (75.57% ± 4.94%, P = 0.0136) compared to uninfected cells (100 ± 3.05) (Fig. 
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19B). The minor impairment of HTNV infection on the cellular adhesion and migration compared to 
PUUV was likely to be caused due to low infection efficiencies.  
In conclusion, Old World hantavirus infections cause an impairment of the adhesion and migration 
capacities in primary podocytes and HREPC, which are comparable to the results obtained in the 
podocyte cell line. 
 
 
Figure 19 Adhesion and migration capacity of HTNV- and PUUV-infected HREPC. (A) Uninfected and HTNV- or 
PUUV-infected HREPC were detached on day nine post infection, plated into 96-wells and numbers of attached 
cells were quantified after one hour by In-Cell Western. Three independent experiments were performed in 
quadruplicates. N protein was stained in red and cells were imaged at a magnification of ×200. Adhesion of 
uninfected cells was set to 100%. Shown is mean ± SD. (B) Migration of uninfected and hantavirus-infected 
HREPC was analyzed by live cell imaging. 100 cells per experiment were analyzed by single-cell-tracking. Three 
independent experiments were performed. Shown is mean ± SD. 
 
3.3 Analysis of underlying hantaviral mechanisms with regards to functional 
consequences 
3.3.1 Soluble factors in supernatant of infected podocytes 
The precise mechanism of how Old World hantaviruses induce kidney damage is not completely 
understood. Analysis of single hantavirus-infected renal cells revealed functional consequences 
mainly affecting the migration. Therefore, to investigate the underlying mechanism, human 
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podocytes were further analyzed for direct virus-specific effects. Moreover, it was examined, if 
soluble factors released by infected cells contributed to the pathogenesis.  
In a first step, supernatants of infected podocytes were analyzed for possible soluble factors causing 
an impairment of motility (Fig. 20). Supernatants were left untreated, UV-treated to inhibit the virus 
replication cycle, or filtrated to remove viral particles. The efficacy of inactivation and removal of 
infectious particles was controlled by inoculation of Vero E6 cells and Western blot analysis (Fig. 20A 
and B). After UV irradiation, the N protein of both virus species was still detectable in the 
supernatant but no infection was observed in Vero E6 cells. Neither infectious particles nor N 
proteins were detected after filtration. The supernatants of both virus species were used for 
subsequent migration assays (Fig. 20C and D). Untreated, UV-treated and filtered supernatants of 
uninfected podocytes were used as controls. The migration capacity of podocytes in the presence of 
infectious HTNV particles was reduced compared to control cells (80.02% ± 3.83% vs. 100% ± 1.02%, 
P = 0.0011) (Fig. 20C). Supernatants with inactivated or removed HTNV particles did not influence the 
migration of podocytes. In contrast, supernatants derived from PUUV-infected podocytes only 
caused a slight but not significant impairment of the migration of uninfected podocytes (Fig. 20D). 
This minor effect was completely abolished by UV treatments or removal of PUUV particles.  
These data show that soluble factors released by hantavirus-infected podocytes do not contribute to 
the reduced migration capacity. Rather, infection itself seems to be responsible for the impaired 
migration.  
 
3.3.2 Soluble factors in human sera 
It might be possible that indirect effects, such as signaling molecules or cytokine production by 
immune cells or other renal cells during hantavirus disease, contribute to podocyte damage in vivo. It 
is known that several cytokines, chemokines or growth factors are upregulated during hantaviral 
infection, which might disturb the migration capacity of podocytes.  
Therefore, sera samples of three patients with serologically-confirmed acute hantavirus infection 
were analyzed for the presence of soluble factors causing an effect on podocyte motility (Tab. 4, Fig. 
21). The clinical course of each patient is visualized by serum creatinine levels. Sera samples were 
collected at acute, peak and remission phases of the clinical course and were used for subsequent 
migration assays with uninfected podocytes in vitro. Podocyte medium was supplemented with 50% 
patient serum simulating the maximum of serum content of regular blood.  
  
Results 46 
Compared to sera of healthy control persons or normal cell culture serum, none of the sera collected 
at different phases of the clinical course induced an effect on the migration of podocytes. Thus, it 
seems that possible soluble factors affecting podocyte migration are not present in the sera.  
 
Figure 20 Migration of podocytes inoculated with cell-free viral supernatants. (A and B) Untreated, UV-
irradiated, and filtrated supernatants from HTNV- (A) and PUUV-infected (B) podocytes were analyzed for the 
presence of N protein by Western blot and for infectivity by inoculation of Vero E6 cells and detection of N 
protein (red) by immunofluorescence. (C and D) Confluent monolayers of uninfected podocytes were seeded 
into µ-plates. Untreated, UV-treated or filtered supernatants of HTNV-(C) or PUUV-infected (D) podocytes were 
added to cells 30 minutes before migration assay. After removal of the insert and after eight hours, cell-free 
areas were measured and relative migration was calculated. Migration of cells incubated with untreated, UV-
treated and filtered supernatants of uninfected podocytes (ctrl) were set to 100%. Experiments were 
performed in triplicates. Shown is mean ± SD. 
 
 
Table 4 Characteristics, peak, and nadir levels of laboratory parameters obtained from three patients with 
acute PUUV hantavirus disease used for migration assays 
Characteristic #64 #176 #211 reference 
Age (yr) 37 53 25 - 
Gender m m m - 
Duration of hospitalization (days) 8 15 10 - 
Max serum creatinine level (mg/dl) 11.94 12.16 10.89 0.1-1.3 
Min serum albumin level (g/liter) 28 31 31.1 30-50 
Max leukocyte count (G/liter) 15.6 15.73 7.57 4-10 
Min platelet count (G/liter) 65 52 49 150-440 
Max LDH
a
 activity (U/liter) 329 405 422 < 248 
Max CRP
b
 level (mg/liter) 94.5 143.7 61.2 < 5 
Point of renal biopsy (dpo
c
) 9 - - - 
a
LDH: lactate dehydrogenase, 
b
CRP: C-reactive protein, 
c
dpo: days post onset 
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Figure 21 Migration capacity of podocytes after inoculation with sera of PUUV-infected patients. Podocytes 
were inoculated with normal podocyte medium containing 10% FCS (-), medium containing 50% serum of 
healthy control persons (ctrl), or with medium containing 50% serum of patients with PUUV infection collected 
during the clinical course. Uninfected podocytes were seeded confluently into µ-plates. Sera were added 30 
minutes before insert removal. After insert removal and after eight hours, cell-free areas were measured and 
relative migration was calculated and shown on the left y-axis. Migration of podocytes in the presence of sera 
derived from three healthy donors (ctrl) was set to 100%. Shown is mean ± SD. Levels of patients’ serum 
creatinine were plotted on the right y-axis. Dashed horizontal line indicates the reference value of serum 
creatinine for healthy persons (<1.3 mg/dl).  
 
 
3.3.3 Effects of recombinantly-expressed hantavirus N proteins  
3.3.3.1 Localization of recombinant N protein in human podocytes 
By investigating supernatants of infected cells or patients’ sera, no indirect effects were found 
contributing to the pathogenesis of podocytes. The absence of soluble factors provides evidence for 
direct virus-dependent damage in podocytes. To determine a possible role of the N protein during 
hantavirus disease, human podocytes were transfected with plasmids encoding for HTNV or PUUV N 
protein. Differentiated podocytes are difficult to transfect with standard methods. Therefore, 
nucleofection was performed to transfer N protein encoding plasmids by electrical pulse to gain an 
efficacy of 10-20% transfected cells.  
First, the localization of N protein alone was analyzed after transfection (Fig. 22A). Similar to N 
protein in infection, recombinantly-expressed N proteins showed a similar pattern with punctate and 
filamentous N protein distribution. The amount of cells showing a filamentous pattern was 23.29% ± 
2.29 for HTNV and 4.33 ± 2.31 for PUUV N protein (Fig. 22B). Again, filamentous HTNV N protein 
partially co-localized with F-actin indicated by the fluorescence intensity profiles. Recombinant PUUV 
N expression displayed a less pronounced association with the actin cytoskeleton (Fig. 22A).  
As seen during infection studies, the filamentous pattern and the association with F-actin are more 
prominent for recombinantly-expressed HTNV N protein.  
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Figure 22 Localization of recombinantly-expressed HTNV and PUUV N protein in podocytes. (A) Podocytes 
were transfected with plasmids encoding N protein of HTNV or PUUV by nucleofection. Localization of N 
proteins (red) and F-actin (green) was analyzed 24 hours after transfection by confocal microscopy at a 
magnification of ×1000. Histograms show fluorescence intensity profiles of F-actin and N protein staining along 
the indicated lines. (B) Podocytes were analyzed for the N protein localization pattern 24 hours after 
transfection. Data were obtained from three independent experiments. Shown is mean ± SD. 
 
3.3.3.2 Effects of recombinant N protein on podocyte migration  
To investigate if hantaviral N proteins alone play a role in the impairment of migration, podocytes 
transfected with plasmids encoding for either HTNV or PUUV N protein were analyzed for their 
migration capacity by live imaging. Due to a low efficacy of podocyte transfection, the migration 
assay was inappropriate for analysis. Instead, the motility of individual transfected podocytes was 
assessed by single-cell-tracking. 
To verify that both motility methods provide similar results, HTNV- and PUUV-infected podocytes 
were also examined by single-cell-tracking (Fig. 23A). By comparison to uninfected cells (100% ± 
3.06%), the migrated distance was decreased to 40.02% ± 1.92%, P < 0.0001 for HTNV- and to 73.35% 
± 4.24%, P = 0.0003 for PUUV-infected podocytes. Stainings of N protein revealed that more than 
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90% of cells were infected. As already observed in the migration assays, the covered distance of 
single podocytes was more affected by HTNV than by PUUV infection. The decrease of the motility 
capacity was comparable to the migration assay and the single-cell-tracking for each virus species, 
showing that this method is suitable for the analysis of transfected cells (see Fig. 23A and Fig. 10C 
and D). Next, possible effects on the motility of podocytes by recombinant HTNV or PUUV N proteins 
were examined (Fig. 23B). Cells were co-transfected with maxGFP to visualize transfected cells during 
live imaging. Immunofluorescence analysis showed that more than 95% of transfected podocytes 
were co-expressing N protein and maxGFP. Analysis of the covered distances revealed that the 
migration of transfected cells was reduced to 46.92% ± 8.85%, P = 0.0017 for HTNV and to 72.90% ± 
7.22%, P = 0.0134 for PUUV N protein compared to mock-transfected cells (100% ± 8.45%). The 
impairment of podocyte migration by transfection of HTNV and PUUV N protein alone was 
comparable to the findings in infected cells.  
Infection and transfection studies revealed that HTNV has a greater effect on podocytes than PUUV. 
To exclude that dissimilar expression levels of both N proteins caused the differences regarding the 
severity of impaired migration, the fluorescence intensity of N protein-transfected podocytes was 
determined (Fig. 23C). The analysis showed equal expression levels of HTNV and PUUV N protein 
indicating that the functional consequences did not depend on the amount, but rather on specific 
differences of the N proteins, between the two virus species.  
Taken together, the transfection experiments demonstrate that the expression of N proteins alone is 
capable to induce functional consequences of human podocytes. 
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Figure 23 Effect of HTNV and PUUV infection or N protein expression on podocyte migration. (A) Migration of 
uninfected and PUUV- or HTNV-infected podocytes was analyzed by live cell imaging. Infection was monitored 
by staining of N proteins (red). 30 cells per experiment  were analyzed by single-cell-tracking. Cells were imaged 
at a magnification of ×400. Three independent experiments were performed. Shown is mean ± SD. (B) 
Migration of podocytes transfected with plasmids encoding for maxGFP and N protein of HTNV or PUUV was 
analyzed by live cell imaging. Cells transfected with pmaxGFP and empty vector served as control (mock). Cells 
were analyzed as described above. Transfection efficacy of maxGFP and N proteins was visualized by 
immunostaining of N proteins (red). Cells were imaged at a magnification of ×400. (C) Mean expression levels 
of N proteins were analyzed by measuring 100 transfected cells for the fluorescence intensity of N protein.  
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4. Discussion 
4.1 Human renal cells as relevant cell culture models to study hantavirus 
disease 
Viruses utilize cellular structures and modulate signaling pathways to successfully enable their 
replication cycle in target cells. The strategy of Old World hantaviruses results in renal disease in the 
human host. The infection predominantly manifests in the kidney and leads to acute renal failure 
with massive proteinuria. The understanding of the viral replication cycle and its effects on host cells 
after infection is of crucial importance to study hantavirus disease. However, the exact underlying 
cellular mechanisms responsible for the organ tropism, leading to renal permeability disorders, are 
unknown. Various factors like immunopathology and direct virus-mediated processes have been 
reported to be involved in hantaviral pathogenesis. Direct effects are often described to be cell type- 
and virus-specific. For that reason, choosing a relevant cell culture model is critical in order to study 
the hantavirus disease.  
In previous publications, the hantaviral replication cycle was often examined in Vero E6 cells which 
are non-human, interferon-deficient and might not portray an ideal cell culture model to analyze 
hantavirus infection. Moreover, functional consequences of infection have not been investigated in 
Vero E6 cells so far. Therefore, the aim of this study is to analyze the effects of Old World 
hantaviruses on a relevant cell culture model. Here, human renal cells, which are important for renal 
filtration and reabsorption processes, were used and compared to Vero E6 cells.  
In the presented work, the hantaviral replication cycle differs enormously between human podocytes 
and Vero E6 cells regarding the localization of viral antigens and the resulting consequences of 
infection. In podocytes, the N proteins of Old World hantaviruses display as a filamentous pattern 
which co-localizes with the actin cytoskeleton and this association increases during infection. 
Previous studies of Ravkov et al. and Ramanathan et al. obtained contradictory results concerning 
the localization of hantaviral N proteins along cytoskeletal components in Vero E6 cells [50, 51, 59]. 
In the presented study, filamentous N protein and F-actin association were not observed in Vero E6 
cells infected either with HTNV or PUUV. The discrepancy of the actin association in Vero E6 cells 
most likely occurs due to the choosing of varying points of time for the examination after infecting 
the cells. While Ramanathan et al. observed no colocalization in the early stages, Ravkov et al. found 
the N protein association with the actin cytoskeleton late during infection in Vero E6 cells. This effect 
complies with the findings in human podocytes in which the filamentous N protein pattern and the 
resulting F-actin association also increase during infection and little N protein localization is seen in 
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early stages. Nevertheless, the infection kinetics in the presented work demonstrate that an actin 
localization of N protein is observed in podocytes and not in Vero E6 cells, opposing the study of 
Ravkov et al. [59]. This difference might occur due to the fact that Ravkov et al. used New World 
hantaviruses, while the experiments in the presented work were performed with hantaviruses of the 
Old World. It might be possible, that hantaviral species utilize cytoskeletal components for their 
replication cycle differently. 
The localization of the Old World hantavirus N proteins in podocytes and in Vero E6 cells might be 
influenced by cell-specific signaling pathways during infection. Due to their interferon deficiency, 
Vero E6 cells are not able to induce interferon-stimulated genes (ISG). ISGs, however, are important 
for the innate immune system and might be involved in the processes leading up to N protein 
localization and functional disturbances. For example, the myxovirus resistance protein A (MxA) is an 
ISG protein with known antiviral effects and is highly upregulated in hantavirus-infected human cells 
[120]. MxA has an actin binding capacity and is able to target the nucleocapsid protein of viruses 
such as of the influenza virus [121, 122]. Similar interactions by MxA or other ISGs might play a role 
during the hantaviral replication cycle and contribute to the punctuate or filamentous distribution of 
N proteins in podocytes.  
Both, the actin cytoskeleton and the microtubular network, are important for different steps of 
various viral replication cycles. Viruses exploit or even rearrange cytoskeletal components for their 
own purpose during assembly and release of infectious particles, a process that may play a role in the 
pathogenesis. For Old World hantaviruses, a correlation between the association of N protein to F-
actin and its dependence on viral release can be found. HTNV N protein strongly co-localizes with the 
actin cytoskeleton in podocytes and its integrity is crucial for viral release. In contrast, the N proteins 
of PUUV associate with F-actin to a lesser extent and its disruption has no effect on the egress of 
infectious particles. The involvement of the microtubular network differs greatly between podocytes 
and Vero E6 cells. While hantaviruses only slightly depend on intact microtubules in podocytes, the 
viral release of HTNV and PUUV was decreased enormously after disruption of this cytoskeletal 
component in Vero E6 cells. This is, in accordance to previous publications, showing that HTNV 
strongly depends on microtubules for replication and release of infectious viruses in Vero E6 cells 
[50, 51].  
The results reveal that the utilization of cytoskeletal components for hantaviral release depends on 
the virus species, but also differs between cell types. Moreover, the fact that the disruption of actin 
has no effect on PUUV and does not completely decrease the release of HTNV in podocytes, indicates 
that hantaviruses might use several release pathways. These observations agree with previous 
studies, indicating, that several sites of hantaviral assembly and budding exist. Old World 
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hantaviruses have been described to replicate in the ERGIC region and bud either into the Golgi 
lumen or at the host plasma membrane in Vero E6 cells [55, 56]. However, the sites of assembly and 
budding of Old World hantaviruses have not been examined in a relevant human renal cell model 
yet. Different egress pathways might also have an impact on the maturation and morphology of viral 
particles and can thereby influence the infectivity and the resulting pathogenesis. The hantaviral lipid 
envelope is derived from host cell membranes of either the Golgi apparatus or the plasma 
membrane. The molecular composition of membranes differs between organelles and host species 
and might have an impact on the pathogenicity. For example, variations in the content of certain 
lipids in the viral envelope are described to influence viral cell attachment or membrane fusion [123]. 
Old World hantaviruses are transmitted from rodents to humans and do not spread through person-
to-person transmission. Moreover, a divergence in the range of viral particle size was already 
observed in hantaviruses isolated either from humans or rodent hosts [56, 124]. Therefore, in order 
to display the natural route of transmission, it should be considered to perform infection studies with 
viruses propagated in rodent cells, for example in the Bank Vole Kidney (BVK) 168 cell line derived 
from the PUUV host Myodes glareolus [125]. 
Old World hantaviruses differ in utilization of the actin cytoskeleton for egress of infectious particles 
and N protein localization in human podocytes and monkey Vero E6 cells. Further research will focus 
on the role of F-actin during hantaviral egress in human renal cells and whether these structures are 
exploited for assembly and/or as pathways for hantaviral release. The association of F-actin and N 
protein during the replication cycle might also be a contributing factor to the functional 
consequences for the target cells since the actin cytoskeleton is responsible for various cellular 
functions such as cell migration, maintenance of cell shape and transport processes. In fact, a 
correlation between the localization of N protein to F-actin and the disturbance of cellular functions 
can be observed. While hantavirus infection decreases the adhesion and migration capacity of 
podocytes, the observed effects are completely absent in Vero E6 cells. Moreover, the amount of F-
actin occurs to be decreased in podocytes and not in Vero E6 cells and indicates that the N protein 
localization might be a factor in the rearrangement of this cytoskeleton component. 
Although podocytes possess properties of primary cells, these cells are still immortalized and act like 
cell lines. Therefore, the relevance of the results obtained in the podocyte cell line was verified in 
human primary cells, which resemble the in vivo conditions more closely. Analysis of hantavirus 
infection in primary podocytes and human renal epithelial primary cells (HREPC), which are isolated 
from the tubules, identifies common characteristics concerning functional consequences and N 
protein localization in renal cells. An infection with hantaviruses leads to a decrease of cell adhesion 
and migration in both primary cell types, similar to the observations in the podocyte cell line. 
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Moreover, the hantaviral N protein displays as filamentous pattern in a comparable amount in 
primary cells. 
Summarized, the localization of hantaviral N protein, modulation of the actin cytoskeleton, release of 
infectious particles, and the functional consequences after hantavirus infection vary distinctively 
between human renal cells and Vero E6 cells. Species-specific characteristics might influence the 
hantaviral replication cycle and can be responsible for a different outcome of infection leading to 
host cell injury. The results also suggest to further study the underlying pathogenesis mechanism of 
Old World hantavirus disease in cells, which are rather related to the human renal target organ. 
Moreover, this study successfully evaluates the podocyte cell line as a new and relevant cell culture 
model to examine hantavirus infections.  
 
4.2 Old World hantaviruses cause morphological and functional changes in 
kidney biopsies 
The kidney function depends on the intact filtration barrier of the glomerular endothelium and 
podocytes, as well as on the reabsorption capacity of the tubular epithelium. Dysfunction of these 
structures during renal disease can result into proteinuria and acute renal failure.  
The electron microscopy studies of renal biopsies of hantavirus-infected patients and the cell culture 
experiments in the presented work show morphological and functional changes in both, podocytes 
and tubular epithelial cells. The importance of the detected disturbances of podocytes and tubular 
epithelial cells in biopsies and in in vitro experiments, as the underlying cause of disease, is 
emphasized by the observed non-selective proteinuria during the clinical course indicating that both 
structures are affected by hantaviruses in humans [94, 95]. After analyzing biopsies of hantavirus-
infected patients, morphological alterations with podocyte foot process effacement are revealed. 
Foot process effacement is typically linked to proteinuric glomerular disease which is driven by a 
rearrangement of the podocyte actin cytoskeleton leading to a loss of the glomerular slit diaphragm, 
foot processes and a disturbance of motility dynamics [81]. In fact, rearrangements of the actin 
cytoskeleton and motility changes can be observed in podocytes after infection in vitro in the 
presented study. The association of foot process effacement and proteinuria in vivo and deteriorated 
podocyte migration capacity in vitro has been described in various signaling pathways, controlling the 
actin cytoskeleton in response to proteinuric stimuli of kidney and model diseases [82, 83, 126]. In 
combination with the findings of other investigators, these results expand the view of hantavirus-
induced renal impairment by adding podocyte injury linked with effacement and proteinuria as a 
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hantaviral target structure [91, 127]. An intact actin cytoskeleton is crucial for the integrity of cell-to-
cell contacts due to its connection to tight and adherens junctions and furthermore the cell motility is 
also important for the tubular epithelium during repair processes after kidney injury [89, 128]. The 
remodulation and/or hijacking of actin for the viral replication cycle might lead to a change in the 
cytoskeleton and subsequent breakdown of cell-to-cell contacts contributing to the enhanced 
permeability during hantavirus disease [65, 129]. 
In summary, podocytes and tubular epithelial cells represent substantial cell types to study the 
pathogenesis pathway of Old World hantaviruses. It would be of interest to examine glomerular 
endothelial cells for similar morphological and functional changes during hantavirus disease. These 
cells have already been shown to be permissive for hantaviruses and display cellular damage after 
infection [65]. It might be possible that a general mechanism of direct viral effects on human cells 
exists contributing to the pathogenesis. 
However, the mechanism causing actin remodeling, disruption of cell-to-cell contacts, and functional 
consequences of these cells, leading to the enhanced cellular permeability, is not well understood 
yet. There has been the assumption that the clinical picture of hantavirus infection is caused by an 
interplay of direct cellular viral effects and indirect immunopathological mechanisms due to 
activation of the immune system. 
In the presented study, non-infectious supernatants derived from infected podocytes and sera from 
hantavirus-infected patients did not have any effect on podocytes in vitro. This result matches the 
observation of Krautkrämer et al. in renal biopsies of hantavirus-infected patients. The analysis of 
renal tubules revealed an association between cell-to-cell contact disruption and expression of 
hantaviral antigens, whereas neighboring uninfected tubules showed no cellular damage [65]. 
Together, these results indicate the absence of systemic soluble factors during hantavirus disease 
leading to the observed functional impairments and suggest that cellular changes during hantaviral 
infection are crucial for causing permeability. This would also explain the organ-specific localization 
of kidney damage for Old World hantaviruses. The connection of cellular damage and N protein 
expression has also been described in tubules of patients with acute hantavirus disease and in a 
macaque model of hantavirus infection [62, 65]. Nevertheless, it is possible that local effects of 
cytokines released by immune or renal cells contribute to hantaviral pathogenesis in vivo, in addition 
to the direct hantaviral effects on functional consequences observed in cell culture. This assumption 
is, at least, demonstrated for endothelial cells. Particular cytokines, which are increased during 
hantavirus infection in vivo, do not only enhance the permeability of HUVEC, but together with HTNV 
infection, induce a hyper responsive cellular permeability in vitro [104, 105].  
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These results of cell culture experiments and biopsies indicate that, besides immunopathological 
effects, virus-direct properties also play a role in causing hantaviral disease. Hantavirus species might 
have acquired virulence determinants leading to cellular alterations and/or manipulation of the 
immune system and thereby determining the severity of the hantaviral clinical picture. 
 
4.3 Determinants of hantavirus virulence 
The severity, as well as, the organ involvement of hantavirus disease differ enormously between Old 
and New World hantaviruses. Moreover, symptoms can vary from a mild form to fatal outcome even 
within the species of Old World hantavirus. The reason for the renal-specific involvement and, in 
addition, the question why the clinical picture varies considerably between hantaviral species, is to 
this day poorly understood.  
In this study, the hantaviruses HTNV and PUUV with diverse seriousness of the clinical symptoms are 
compared in renal cells in vitro. The two species differ in the cellular actin localization and their 
potential to cause functional consequences. The impairment of renal cells after infection is more 
pronounced for HTNV than for PUUV. These observations from cell culture experiments are 
compliant with the hantaviral clinical picture of both species with HTNV having the more pathogenic 
potential [46]. 
Various factors have been discussed as the possible underlying cause leading to the disease severity 
of hantavirus species. A correlation between high viral plasma RNA levels at early stages of disease 
and a severe clinical picture was found in Old World hantavirus-infected patients [130-132]. 
Interestingly, the viral load of the more pathogenic hantaviruses HTNV and DOBV was higher than 
the viral load of PUUV indicating a replication advantage of distinct hantavirus species, that might 
contribute to disease severity. It is unknown if a high viral titer at the onset of disease is important 
for a viral spread in humans causing initial effects and a stronger renal manifestation. The viral RNA 
levels decrease during later stages of disease and are comparable among hantavirus species, which 
indicates that other mechanisms play an important role in the pathogenesis. Moreover, analysis of 
the cellular functional consequences in the presented study demonstrate that even single cells are 
disturbed in their function and the severity varies between HTNV and PUUV. Therefore, it can be 
concluded that hantavirus species have a different potential to cause cellular damage in target cells 
in vitro.  
By now, little is known about hantavirus-induced deterioration of signaling pathways and processes 
that alter the host cell machinery to facilitate the replication cycle and/or circumvent defense 
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mechanisms that might have an impact on hantavirus pathogenicity. Both, pathogenic and 
nonpathogenic hantaviruses are able to infect the same cell types, suggesting that specific virus-cell 
interactions contribute to the disease severity [47, 120]. 
The entry pathway of hantaviruses is discussed to be directly involved in the pathogenesis since 
pathogenic hantaviruses use integrin αvβ3 in contrast to nonpathogenic species, which enter cells by 
utilizing integrin α5β1 [47]. This might have functional consequences due to activation of cellular 
signaling pathways since integrin αvβ3 is involved in migration and tissue organization [133]. 
Gavrilovskaya et al. already demonstrated that pathogenic hantaviruses inhibit the integrin β3-
migration of HUVEC [134]. Interestingly, integrin αvβ3 has been reported to form signaling complexes 
with uPAR which is elevated in the plasma of hantavirus infected patients [103]. The induction of 
uPAR has been reported to control cellular migration and was described to cause proteinuria and FP 
effacement during kidney disease via a mechanistic link with integrin αvβ3 [83, 135, 136]. The 
activation of uPAR and the involvement of integrin αvβ3 during hantavirus disease might display a 
possible mechanism contributing to the clinical picture of pathogenic hantaviruses. It would be of 
interest to study uPAR in more detail in order to analyze if the observed elevated levels contribute to 
local effects of hantavirus disease. However, the usage of integrin αvβ3 does neither explain the 
spectrum of the severity between pathogenic hantaviruses, nor the organ-specific manifestation 
since integrin αvβ3 is an abundant surface protein. 
Viruses evolved strategies to manipulate the gene expression of host cells in order to facilitate the 
viral replication cycle, shut down the antiviral response, or inhibit the expression of specific proteins 
which enable the dissemination of infectious particles. Analysis of mRNA levels in infected epithelial 
and endothelial cells demonstrated that cellular genes are specifically regulated by different 
hantaviruses. Alterations in the cellular gene expression pattern were found between pathogenic and 
nonpathogenic hantaviruses, as well as, between HFRS- and HCPS-causing species which might 
contribute to the distinct clinical pictures [120]. Interestingly, the cellular expression profiles after 
infection also vary between various DOBV genotypes, indicating differences even in between highly-
related hantaviruses [137].  
However, species-specific factors and genetic alterations responsible for the different hantaviral 
virulence still remain to be determined. First evidence that specific viral genomic sequences might be 
involved in the mechanism of disease was obtained by the work of Kirsanovs et al. with genotypes of 
DOBV, which have different pathogenic potentials [138]. The authors performed DOBV reassortment 
experiments in vitro regarding the induction of the innate immune response with the highly virulent 
subtype DOBV-Dobrava and the weakly pathogenic subtype DOBV-Kurkino (see Tab. 1). It was 
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demonstrated that the virulence was determined by the L segment and S segment encoding for RdRP 
and N protein, respectively. 
 
4.4 Hantaviral N protein as virulence factor 
Hantaviral N proteins have been reported to coordinate the viral replication cycle by multiple 
functions and binding partners. However, little is known about the pathogenesis role of Old World 
hantavirus N proteins in interfering with cellular signaling pathways or host structures which might 
contribute to the clinical picture of enhanced permeability.  
Here, in the presented study, it is demonstrated that the expression of recombinant hantaviral N 
protein alone is able to partly co-localize with F-actin and is sufficient to cause functional 
consequences in podocytes. The effect of recombinantly-expressed HTNV N protein on the motility 
of podocytes is more prominent than for PUUV N which corresponds to the clinical severity and the 
results obtained during infection experiments. Since the expression levels of HTNV and PUUV N 
protein are comparable in transfected cells, the severity of impaired function is not caused by a 
varying cellular amount of N proteins but rather by species-specific N protein differences. Previous 
publications analyzed the role of New World hantaviral N proteins and demonstrated pathogenesis 
properties by interfering with host cell signaling pathways. Cimica et al. showed in transfection 
experiments of human embryonic kidney 293T (HEK293T) cells that the ANDV N protein carries an 
immune-regulating determinant that interferes with signaling pathways of the innate immune 
response [112]. Interestingly, the effect was completely absent after transfection of the N proteins of 
the other HCPS-causing hantavirus Sin Nombre (SNV) and New York-1 (NY-1) virus, indicating 
virulence-determining differences even in highly homolog species. The work of Gorbunova et al. 
revealed that the expression of ANDV N protein in pulmonary endothelial cells activates signaling 
pathways leading to the activation of the small GTPase RhoA which resulted in an enhanced 
permeability [113].  
The data gathered in this work and by other investigators demonstrate that N proteins of New and 
Old World hantaviruses act as a virulence factor interfering with cellular signaling and structures, 
which leads to the clinical picture of hantavirus disease. Nevertheless, further research is required to 
identify virulence elements within the N protein sequence. 
The observations in the presented study show that the N protein of Old World hantaviruses during 
infection and by recombinantly expression is associated with F-actin. Thereby, this interaction might 
have an impact on the cytoskeleton organization responsible for the breakdown of proper cell-to-cell 
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contacts and permeability disorders during infection [65]. Hijacking or reorganization of cellular actin 
through different viral strategies play a crucial role during the replication cycles of many viruses. The 
modification of actin structures is often caused by viral proteins interfering with cell signaling 
pathways or in recruitment of actin-remodeling proteins.  
Podocytes also represent target cells during HIV infection resulting in the clinical picture of HIV-
associated nephropathy (HIVAN) which is characterized by foot process effacement and proteinuria 
[139]. The HIV accessory protein Nef has been identified to play an important role in the 
development of HIVAN. As observed during hantavirus infection for N protein, Nef colocalized with F-
actin, altered the actin cytoskeleton and caused functional consequences in podocytes [140]. The 
morphological changes are mediated by the association of Nef with the diaphanous interacting 
protein which is a regulator of small GTPases leading to actin changes [141]. Moreover, treatment of 
epithelial monolayers with Nef resulted in loss of cell-to-cell contact proteins and enhanced 
permeability [142]. HIV Nef and hantaviral N protein might share similarities in causing podocyte 
damage. Enzymatic activities have not been described for both proteins and cellular changes are 
most likely mediated due to interaction with host proteins. Similar to hantaviral N protein, Nef is a 
small protein, which has various functions during the viral replication cycle leading to manipulations 
of the host cell machinery. For Nef, several sequence motifs have already been identified interacting 
with host proteins involved in pathogenesis due to changes in cellular trafficking or signaling [143].  
Until now, specific binding and interaction motifs in N proteins of hantavirus species contributing to 
the pathogenesis have not yet been identified. Analysis of the N protein sequence in the eukaryotic 
linear motif (ELM) resource database reveal seminal functional motifs as identified in Nef, which, 
however, have to be experimentally verified [144]. Hantaviral N proteins might also be capable of 
interacting with specific proteins in human renal cells and it would be of great interest to identify 
cellular interaction partners involved in pathogenesis. Old World hantaviruses differ enormously in 
their severity in vivo and effects on cells in vitro even between highly related species. Therefore, 
future research will also have to focus on the analysis of N proteins of different hantavirus species. 
The identification of virulence domains within the protein sequence that are responsible for the 
cellular localization and functional damage might help to understand the pathogenesis mechanism of 
hantavirus disease. Analysis of the HTNV and PUUV N protein sequences in the ELM resource 
database indicate a theoretical PDZ (abbreviation of post synaptic density protein, Drosophila disc 
large tumor suppressor, and zonula occludens-1 protein) binding domain for both species. PDZ 
domains can be found in many scaffolding proteins which maintain the formation of signaling 
pathways, cell-to-cell contact complexes, and its anchoring to the cytoskeleton. Many viral proteins 
such as of coronaviruses or human papilloma viruses interfere with the assembly of cell-to-cell 
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contact complexes via PDZ binding motives, leading to a breakdown of the cell barrier [145, 146]. 
Similar mechanisms are conceivable for N proteins since a breakdown and redistribution of the tight 
junction protein ZO-1 was detected during hantavirus infection [65]. Furthermore, a possible actin 
binding domain is found in the N protein sequence of HTNV but is absent in PUUV. This finding might 
explain why the N protein of HTNV is frequently more often associated with the actin cytoskeleton. It 
is possible that N proteins of hantavirus species contain a variable amount of virulence-determining 
domains and are able to differentially interact with host structures which might explain the varying 
severity of the clinical course. However, the putative PDZ and actin binding domains have to be 
experimentally proven. 
In summary, the presented study demonstrates that hantavirus infection causes morphological and 
functional changes of podocytes and the tubular epithelium in cell culture experiments and renal 
human biopsies that play a key role in kidney function. Moreover, the cellular alterations by 
hantaviruses are species-specific and suggest the study of the pathogenesis mechanisms in relevant 
human cell models. The results also reveal an important role of Old World hantaviral N proteins as 
virulence factor. The severity of HTNV and PUUV N protein concerning the impairment of podocytes 
suggest alterations within the N protein sequence that are crucial for interaction with host proteins. 
These findings provide useful insight into the clinical picture of Old World hantaviruses leading to the 
clinical picture of HFRS. 
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